{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:49:12Z","timestamp":1791578952414,"version":"4.3.4"},"reference-count":306,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41582-026-01244-5","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:33:53Z","timestamp":1786372433000},"page":"581-601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Menopause and neurological disorders: a roadmap for research"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2034-8800","authenticated-orcid":false,"given":"Riley","family":"Bove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2993-585X","authenticated-orcid":false,"given":"Ruth","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"1244_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-024-00692-2","author":"X Shen","year":"2024","unstructured":"Shen, X. et al. Nonlinear dynamics of multi-omics profiles during human aging. Nat. Aging https:\/\/doi.org\/10.1038\/s43587-024-00692-2 (2024).","journal-title":"Nat. Aging"},{"key":"1244_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.psyneuen.2019.03.013","volume":"106","author":"MK Georgakis","year":"2019","unstructured":"Georgakis, M. K., Beskou-Kontou, T., Theodoridis, I., Skalkidou, A. & Petridou, E. T. Surgical menopause in association with cognitive function and risk of dementia: a systematic review and meta-analysis. Psychoneuroendocrinology 106, 9\u201319 (2019).","journal-title":"Psychoneuroendocrinology"},{"key":"1244_CR3","doi-asserted-by":"publisher","first-page":"106393","DOI":"10.1016\/j.psyneuen.2023.106393","volume":"158","author":"JJ Steventon","year":"2023","unstructured":"Steventon, J. J. et al. Menopause age, reproductive span and hormone therapy duration predict the volume of medial temporal lobe brain structures in postmenopausal women. Psychoneuroendocrinology 158, 106393 (2023).","journal-title":"Psychoneuroendocrinology"},{"key":"1244_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrendo.2015.82","volume":"11","author":"RD Brinton","year":"2015","unstructured":"Brinton, R. D., Yao, J., Yin, F., Mack, W. J. & Cadenas, E. Perimenopause as a neurological transition state. Nat. Rev. Endocrinol. 11, 393\u2013405 (2015).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1244_CR5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3109\/13697137.2012.666916","volume":"15","author":"RD Langer","year":"2012","unstructured":"Langer, R. D., Manson, J. E. & Allison, M. A. Have we come full circle \u2014 or moved forward? The Women\u2019s Health Initiative 10 years on. Climacteric 15, 206\u2013212 (2012).","journal-title":"Climacteric"},{"key":"1244_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","volume":"362","author":"V Beral","year":"2003","unstructured":"Beral, V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362, 419\u2013427 (2003).","journal-title":"Lancet"},{"key":"1244_CR7","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1210\/jc.2011-3362","volume":"97","author":"SD Harlow","year":"2012","unstructured":"Harlow, S. D. et al. Executive summary of the Stages of Reproductive Aging Workshop\u2009+\u200910: addressing the unfinished agenda of staging reproductive aging. J. Clin. Endocrinol. Metab. 97, 1159\u20131168 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1244_CR8","doi-asserted-by":"publisher","first-page":"eads8169","DOI":"10.1126\/sciadv.ads8169","volume":"11","author":"M Gadek","year":"2025","unstructured":"Gadek, M. et al. Aging activates escape of the silent X chromosome in the female mouse hippocampus. Sci. Adv. 11, eads8169 (2025).","journal-title":"Sci. Adv."},{"key":"1244_CR9","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/gerona\/glad007","volume":"78","author":"CK Shaw","year":"2023","unstructured":"Shaw, C. K. et al. X chromosome factor Kdm6a enhances cognition independent of its demethylase function in the aging XY male brain. J. Gerontol. A 78, 938\u2013943 (2023).","journal-title":"J. Gerontol. A"},{"key":"1244_CR10","doi-asserted-by":"publisher","unstructured":"Marino, F., Wang, D., Merrihew, G. E., MacCoss, M. J. & Dubal, D. B. A second X chromosome improves cognition in aging male and female mice. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.07.26.605328 (2024).","DOI":"10.1101\/2024.07.26.605328"},{"key":"1244_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12871","volume":"18","author":"EJ Davis","year":"2019","unstructured":"Davis, E. J., Lobach, I. & Dubal, D. B. Female XX sex chromosomes increase survival and extend lifespan in aging mice. Aging Cell 18, e12871 (2019).","journal-title":"Aging Cell"},{"key":"1244_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41586-024-08457-y","volume":"638","author":"S Abdulai-Saiku","year":"2025","unstructured":"Abdulai-Saiku, S. et al. The maternal X chromosome affects cognition and brain ageing in female mice. Nature 638, 152\u2013159 (2025).","journal-title":"Nature"},{"key":"1244_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/sj.ejhg.5201398","volume":"13","author":"M Kristiansen","year":"2005","unstructured":"Kristiansen, M. et al. Twin study of genetic and aging effects on X chromosome inactivation. Eur. J. Hum. Genet. 13, 599\u2013606 (2005).","journal-title":"Eur. J. Hum. Genet."},{"key":"1244_CR14","doi-asserted-by":"publisher","first-page":"105631","DOI":"10.1016\/j.yhbeh.2024.105631","volume":"165","author":"K Konishi","year":"2024","unstructured":"Konishi, K. et al. Leukocyte telomere length and memory circuitry and cognition in early aging: impact of sex and menopausal status. Horm. Behav. 165, 105631 (2024).","journal-title":"Horm. Behav."},{"key":"1244_CR15","doi-asserted-by":"publisher","first-page":"8756","DOI":"10.1523\/JNEUROSCI.0663-23.2023","volume":"43","author":"A Crestol","year":"2023","unstructured":"Crestol, A. et al. Menopause status and within-group differences in chronological age affect the functional neural correlates of spatial context memory in middle-aged females. J. Neurosci. 43, 8756\u20138768 (2023).","journal-title":"J. Neurosci."},{"key":"1244_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1192\/bjp.2025.35","volume":"226","author":"LAM Galea","year":"2025","unstructured":"Galea, L. A. M. Translational perspectives on women\u2019s mental health. Br. J. Psychiatry 226, 331\u2013333 (2025).","journal-title":"Br. J. Psychiatry"},{"key":"1244_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41574-024-01061-0","volume":"21","author":"BH Lee","year":"2025","unstructured":"Lee, B. H., Eid, R. S., Hodges, T. E., Barth, C. & Galea, L. A. M. Leveraging research into sex differences and steroid hormones to improve brain health. Nat. Rev. Endocrinol. 21, 214\u2013229 (2025).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1244_CR18","doi-asserted-by":"publisher","first-page":"100434","DOI":"10.1016\/j.coemr.2023.100434","volume":"28","author":"HA Bimonte-Nelson","year":"2023","unstructured":"Bimonte-Nelson, H. A. & Bernaud, V. E. How preclinical models of menopause can inform clinical care: a focus on midlife and reciprocal communication between clinical and preclinical science. Curr. Opin. Endocr. Metab. Res. 28, 100434 (2023).","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"1244_CR19","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s43587-023-00509-8","volume":"3","author":"G Gilmer","year":"2023","unstructured":"Gilmer, G. et al. Female aging: when translational models don\u2019t translate. Nat. Aging 3, 1500\u20131508 (2023).","journal-title":"Nat. Aging"},{"key":"1244_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.31887\/DCNS.2002.4.2\/ddubal","volume":"4","author":"DB Dubal","year":"2002","unstructured":"Dubal, D. B. & Wise, P. M. Estrogen and neuroprotection: from clinical observations to molecular mechanisms. Dialogues Clin. Neurosci. 4, 149\u2013161 (2002).","journal-title":"Dialogues Clin. Neurosci."},{"key":"1244_CR21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S2213-8587(23)00224-3","volume":"11","author":"C Barth","year":"2023","unstructured":"Barth, C., Crestol, A., de Lange, A. G. & Galea, L. A. M. Sex steroids and the female brain across the lifespan: insights into risk of depression and Alzheimer\u2019s disease. Lancet Diabetes Endocrinol. 11, 926\u2013941 (2023).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1244_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41723-7","volume":"14","author":"N Itoh","year":"2023","unstructured":"Itoh, N. et al. Estrogen receptor beta in astrocytes modulates cognitive function in mid-age female mice. Nat. Commun. 14, 6044 (2023).","journal-title":"Nat. Commun."},{"key":"1244_CR23","doi-asserted-by":"publisher","first-page":"14813","DOI":"10.1073\/pnas.0703783104","volume":"104","author":"S Tiwari-Woodruff","year":"2007","unstructured":"Tiwari-Woodruff, S., Morales, L. B., Lee, R. & Voskuhl, R. R. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)\u03b1 and ER\u03b2 ligand treatment. Proc. Natl Acad. Sci. USA 104, 14813\u201314818 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1244_CR24","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/labinvest.2012.76","volume":"92","author":"MO Ziehn","year":"2012","unstructured":"Ziehn, M. O., Avedisian, A. A., Dervin, S. M., O\u2019Dell, T. J. & Voskuhl, R. R. Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease. Lab. Invest. 92, 1234\u20131245 (2012).","journal-title":"Lab. Invest."},{"key":"1244_CR25","doi-asserted-by":"publisher","first-page":"106088","DOI":"10.1016\/j.bbi.2025.106088","volume":"130","author":"JE Richard","year":"2025","unstructured":"Richard, J. E. et al. Sex-specific metabolic and central effects of GLP-1-estradiol conjugate in middle-aged rats on a standard or western diet. Brain Behav. Immun. 130, 106088 (2025).","journal-title":"Brain Behav. Immun."},{"key":"1244_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1210\/endo.142.1.7911","volume":"142","author":"DB Dubal","year":"2001","unstructured":"Dubal, D. B. & Wise, P. M. Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 142, 43\u201348 (2001).","journal-title":"Endocrinology"},{"key":"1244_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-14-118","volume":"14","author":"YL Ma","year":"2013","unstructured":"Ma, Y. L. et al. The effects of different doses of estradiol (E2) on cerebral ischemia in an in vitro model of oxygen and glucose deprivation and reperfusion and in a rat model of middle carotid artery occlusion. BMC Neurosci. 14, 118 (2013).","journal-title":"BMC Neurosci."},{"key":"1244_CR28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1097\/00004647-199811000-00012","volume":"18","author":"DB Dubal","year":"1998","unstructured":"Dubal, D. B. et al. Estradiol protects against ischemic injury. J. Cereb. Blood Flow Metab. 18, 1253\u20131258 (1998).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"1244_CR29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1161\/01.STR.30.3.630","volume":"30","author":"Q Wang","year":"1999","unstructured":"Wang, Q., Santizo, R., Baughman, V. L., Pelligrino, D. A. & Iadecola, C. Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats. Stroke 30, 630\u2013637 (1999).","journal-title":"Stroke"},{"key":"1244_CR30","doi-asserted-by":"publisher","first-page":"105074","DOI":"10.1016\/j.neubiorev.2023.105074","volume":"146","author":"A Shvetcov","year":"2023","unstructured":"Shvetcov, A. et al. The neuroprotective effects of estrogen and estrogenic compounds in spinal cord injury. Neurosci. Biobehav. Rev. 146, 105074 (2023).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1244_CR31","doi-asserted-by":"publisher","first-page":"732694","DOI":"10.3389\/fimmu.2021.732694","volume":"12","author":"JT Keane","year":"2021","unstructured":"Keane, J. T. et al. Gender and the sex hormone estradiol affect multiple sclerosis risk gene expression in Epstein-Barr virus-infected B cells. Front. Immunol. 12, 732694 (2021).","journal-title":"Front. Immunol."},{"key":"1244_CR32","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1007\/s11033-019-05048-3","volume":"46","author":"R Heidari Barchi Nezhad","year":"2019","unstructured":"Heidari Barchi Nezhad, R. et al. The effects of transplanted mesenchymal stem cells treated with 17-b estradiol on experimental autoimmune encephalomyelitis. Mol. Biol. Rep. 46, 6135\u20136146 (2019).","journal-title":"Mol. Biol. Rep."},{"key":"1244_CR33","doi-asserted-by":"publisher","first-page":"105598","DOI":"10.1016\/j.yhbeh.2024.105598","volume":"164","author":"J Lymer","year":"2024","unstructured":"Lymer, J. et al. The effects of estrogens on spatial learning and memory in female rodents - a systematic review and meta-analysis. Horm. Behav. 164, 105598 (2024).","journal-title":"Horm. Behav."},{"key":"1244_CR34","doi-asserted-by":"publisher","first-page":"100787","DOI":"10.1016\/j.yfrne.2019.100787","volume":"55","author":"I Azcoitia","year":"2019","unstructured":"Azcoitia, I., Barreto, G. E. & Garcia-Segura, L. M. Molecular mechanisms and cellular events involved in the neuroprotective actions of estradiol. Analysis of sex differences. Front. Neuroendocrinol. 55, 100787 (2019).","journal-title":"Front. Neuroendocrinol."},{"key":"1244_CR35","doi-asserted-by":"publisher","first-page":"105773","DOI":"10.1016\/j.yhbeh.2025.105773","volume":"173","author":"KM Frick","year":"2025","unstructured":"Frick, K. M. et al. Not your mother\u2019s hormone therapy: highly selective estrogen receptor beta agonists as next-generation therapies for menopausal symptom relief. Horm. Behav. 173, 105773 (2025).","journal-title":"Horm. Behav."},{"key":"1244_CR36","doi-asserted-by":"publisher","first-page":"100189","DOI":"10.1016\/j.labinv.2023.100189","volume":"103","author":"CE Meyer","year":"2023","unstructured":"Meyer, C. E. et al. Neuroprotection in cerebral cortex induced by the pregnancy hormone estriol. Lab. Invest. 103, 100189 (2023).","journal-title":"Lab. Invest."},{"key":"1244_CR37","doi-asserted-by":"publisher","first-page":"696838","DOI":"10.3389\/fnbeh.2021.696838","volume":"15","author":"SV Koebele","year":"2021","unstructured":"Koebele, S. V. et al. Clinically used hormone formulations differentially impact memory, anxiety-like, and depressive-like behaviors in a rat model of transitional menopause. Front. Behav. Neurosci. 15, 696838 (2021).","journal-title":"Front. Behav. Neurosci."},{"key":"1244_CR38","doi-asserted-by":"publisher","first-page":"885321","DOI":"10.3389\/fnins.2022.885321","volume":"16","author":"SV Koebele","year":"2022","unstructured":"Koebele, S. V. et al. Evaluating the cognitive impacts of drospirenone, a spironolactone-derived progestin, independently and in combination with ethinyl estradiol in ovariectomized adult rats. Front. Neurosci. 16, 885321 (2022).","journal-title":"Front. Neurosci."},{"key":"1244_CR39","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/gme.0b013e31824d1fc4","volume":"19","author":"NC Chisholm","year":"2012","unstructured":"Chisholm, N. C. & Juraska, J. M. Effects of long-term treatment with estrogen and medroxyprogesterone acetate on synapse number in the medial prefrontal cortex of aged female rats. Menopause 19, 804\u2013811 (2012).","journal-title":"Menopause"},{"key":"1244_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/biom10020225","volume":"10","author":"MD Spritzer","year":"2020","unstructured":"Spritzer, M. D. & Roy, E. A. Testosterone and adult neurogenesis. Biomolecules 10, 225 (2020).","journal-title":"Biomolecules"},{"key":"1244_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.nlm.2008.04.002","volume":"90","author":"JS Talboom","year":"2008","unstructured":"Talboom, J. S., Williams, B. J., Baxley, E. R., West, S. G. & Bimonte-Nelson, H. A. Higher levels of estradiol replacement correlate with better spatial memory in surgically menopausal young and middle-aged rats. Neurobiol. Learn. Mem. 90, 155\u2013163 (2008).","journal-title":"Neurobiol. Learn. Mem."},{"key":"1244_CR42","doi-asserted-by":"publisher","first-page":"105710","DOI":"10.1016\/j.yhbeh.2025.105710","volume":"170","author":"JC Flannery","year":"2025","unstructured":"Flannery, J. C., Tirrell, P. S., Baumgartner, N. E. & Daniel, J. M. Neuroestrogens, the hippocampus, and female cognitive aging. Horm. Behav. 170, 105710 (2025).","journal-title":"Horm. Behav."},{"key":"1244_CR43","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.tree.2015.04.011","volume":"30","author":"DP Croft","year":"2015","unstructured":"Croft, D. P., Brent, L. J., Franks, D. W. & Cant, M. A. The evolution of prolonged life after reproduction. Trends Ecol. Evol. 30, 407\u2013416 (2015).","journal-title":"Trends Ecol. Evol."},{"key":"1244_CR44","doi-asserted-by":"publisher","unstructured":"Kim, M. et al. Systematic characterization of the ovarian landscape across mouse menopause models. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.06.10.658920 (2025).","DOI":"10.1101\/2025.06.10.658920"},{"key":"1244_CR45","doi-asserted-by":"publisher","first-page":"105680","DOI":"10.1016\/j.yhbeh.2025.105680","volume":"168","author":"A Mashimo","year":"2025","unstructured":"Mashimo, A. et al. Hormonal fluctuations in rodent models using 4-vinylcyclohexene diepoxide: a systematic review and meta-analysis. Horm. Behav. 168, 105680 (2025).","journal-title":"Horm. Behav."},{"key":"1244_CR46","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1210\/en.2008-1802","volume":"150","author":"JI Acosta","year":"2009","unstructured":"Acosta, J. I. et al. Transitional versus surgical menopause in a rodent model: etiology of ovarian hormone loss impacts memory and the acetylcholine system. Endocrinology 150, 4248\u20134259 (2009).","journal-title":"Endocrinology"},{"key":"1244_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.yhbeh.2016.10.010","volume":"87","author":"SV Koebele","year":"2017","unstructured":"Koebele, S. V. et al. Cognitive changes across the menopause transition: a longitudinal evaluation of the impact of age and ovarian status on spatial memory. Horm. Behav. 87, 96\u2013114 (2017).","journal-title":"Horm. Behav."},{"key":"1244_CR48","doi-asserted-by":"publisher","first-page":"112607","DOI":"10.1016\/j.exger.2024.112607","volume":"197","author":"NZ Ramli","year":"2024","unstructured":"Ramli, N. Z. et al. Spatial learning and memory impairment at the post-follicular depletion state is associated with reduced hippocampal glucose uptake. Exp. Gerontol. 197, 112607 (2024).","journal-title":"Exp. Gerontol."},{"key":"1244_CR49","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1210\/en.2014-1190","volume":"155","author":"TA Van Kempen","year":"2014","unstructured":"Van Kempen, T. A. et al. Characterization of neural estrogen signaling and neurotrophic changes in the accelerated ovarian failure mouse model of menopause. Endocrinology 155, 3610\u20133623 (2014).","journal-title":"Endocrinology"},{"key":"1244_CR50","doi-asserted-by":"publisher","first-page":"1597130","DOI":"10.3389\/fmolb.2025.1597130","volume":"12","author":"R Marongiu","year":"2025","unstructured":"Marongiu, R. et al. Promotion of neuroinflammation in select hippocampal regions in a mouse model of perimenopausal Alzheimer\u2019s disease. Front. Mol. Biosci. 12, 1597130 (2025).","journal-title":"Front. Mol. Biosci."},{"key":"1244_CR51","doi-asserted-by":"publisher","first-page":"61.e61","DOI":"10.1016\/j.ajog.2022.02.022","volume":"227","author":"PL Mai","year":"2022","unstructured":"Mai, P. L. et al. Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology\/Gynecologic Oncology Group study. Am. J. Obstet. Gynecol. 227, 61.e61\u201361.e18 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1244_CR52","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/13697137.2018.1535584","volume":"22","author":"FZ Stanczyk","year":"2019","unstructured":"Stanczyk, F. Z. et al. Circulating androgen levels before and after oophorectomy in premenopausal and postmenopausal women. Climacteric 22, 169\u2013174 (2019).","journal-title":"Climacteric"},{"key":"1244_CR53","first-page":"216","volume":"2","author":"N Kuwahara","year":"2021","unstructured":"Kuwahara, N., Nicholson, K., Isaacs, L. & MacLusky, N. J. Androgen effects on neural plasticity. Androg. Clin. Res. Ther. 2, 216\u2013230 (2021).","journal-title":"Androg. Clin. Res. Ther."},{"key":"1244_CR54","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1530\/JOE-20-0578","volume":"249","author":"I Salinas","year":"2021","unstructured":"Salinas, I., Sinha, N. & Sen, A. Androgen-induced epigenetic modulations in the ovary. J. Endocrinol. 249, R53\u2013r64 (2021).","journal-title":"J. Endocrinol."},{"key":"1244_CR55","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.steroids.2010.01.012","volume":"75","author":"IA Blair","year":"2010","unstructured":"Blair, I. A. Analysis of estrogens in serum and plasma from postmenopausal women: past present, and future. Steroids 75, 297\u2013306 (2010).","journal-title":"Steroids"},{"key":"1244_CR56","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.celrep.2014.03.076","volume":"7","author":"DB Dubal","year":"2014","unstructured":"Dubal, D. B. et al. Life extension factor klotho enhances cognition. Cell Rep. 7, 1065\u20131076 (2014).","journal-title":"Cell Rep."},{"key":"1244_CR57","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3390\/biom13091405","volume":"13","author":"S Arjmand","year":"2023","unstructured":"Arjmand, S., Bender, D., Jakobsen, S., Wegener, G. & Landau, A. M. Peering into the brain\u2019s estrogen receptors: pet tracers for visualization of nuclear and extranuclear estrogen receptors in brain disorders. Biomolecules 13, 1405 (2023).","journal-title":"Biomolecules"},{"key":"1244_CR58","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3390\/medicina57121320","volume":"57","author":"AM Panaitescu","year":"2021","unstructured":"Panaitescu, A. M., Popescu, M. R., Ciobanu, A. M., Gica, N. & Cimpoca-Raptis, B. A. Pregnancy complications can foreshadow future disease-long-term outcomes of a complicated pregnancy. Medicina 57, 1320 (2021).","journal-title":"Medicina"},{"key":"1244_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03550-5","volume":"22","author":"M Singh","year":"2024","unstructured":"Singh, M. et al. Pregnancy complications and autoimmune diseases in women: systematic review and meta-analysis. BMC Med. 22, 339 (2024).","journal-title":"BMC Med."},{"key":"1244_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03284-4","volume":"22","author":"S Wambua","year":"2024","unstructured":"Wambua, S. et al. Association between pregnancy-related complications and development of type 2 diabetes and hypertension in women: an umbrella review. BMC Med. 22, 66 (2024).","journal-title":"BMC Med."},{"key":"1244_CR61","unstructured":"National Heart, Lung and Blood Institute. Pregnancy is like the ultimate stress test: what new prospective parents need to know about heart health. NHLBI https:\/\/www.nhlbi.nih.gov\/news\/2022\/pregnancy-ultimate-stress-test-what-new-prospective-parents-need-know-about-heart-health (2022)."},{"key":"1244_CR62","doi-asserted-by":"publisher","first-page":"101542","DOI":"10.1016\/j.arr.2021.101542","volume":"74","author":"A Mishra","year":"2022","unstructured":"Mishra, A. et al. A tale of two systems: lessons learned from female mid-life aging with implications for Alzheimer\u2019s prevention & treatment. Ageing Res. Rev. 74, 101542 (2022).","journal-title":"Ageing Res. Rev."},{"key":"1244_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185926","volume":"12","author":"L Mosconi","year":"2017","unstructured":"Mosconi, L. et al. Perimenopause and emergence of an Alzheimer\u2019s bioenergetic phenotype in brain and periphery. PLoS ONE 12, e0185926 (2017).","journal-title":"PLoS ONE"},{"key":"1244_CR64","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.21599.1","volume":"9","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Mishra, A. & Brinton, R. D. Transitions in metabolic and immune systems from pre-menopause to post-menopause: implications for age-associated neurodegenerative diseases. F1000Res 9, F1000 (2020).","journal-title":"F1000Res"},{"key":"1244_CR65","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1001\/jama.2020.1757","volume":"323","author":"GA Greendale","year":"2020","unstructured":"Greendale, G. A., Karlamangla, A. S. & Maki, P. M. The menopause transition and cognition. J. Am. Med. Assoc. 323, 1495\u20131496 (2020).","journal-title":"J. Am. Med. Assoc."},{"key":"1244_CR66","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/152460901750269670","volume":"10","author":"E Sullivan Mitchell","year":"2001","unstructured":"Sullivan Mitchell, E. & Fugate Woods, N. Midlife women\u2019s attributions about perceived memory changes: observations from the seattle midlife women\u2019s health study. J. Womens Health Gend. Based Med. 10, 351\u2013362 (2001).","journal-title":"J. Womens Health Gend. Based Med."},{"key":"1244_CR67","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1097\/GME.0000000000000705","volume":"23","author":"AE Unkenstein","year":"2016","unstructured":"Unkenstein, A. E., Bryant, C. A., Judd, F. K., Ong, B. & Kinsella, G. J. Understanding women\u2019s experience of memory over the menopausal transition: subjective and objective memory in pre-, peri-, and postmenopausal women. Menopause 23, 1319\u20131329 (2016).","journal-title":"Menopause"},{"key":"1244_CR68","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/gme.0b013e318241fd22","volume":"19","author":"MT Weber","year":"2012","unstructured":"Weber, M. T., Mapstone, M., Staskiewicz, J. & Maki, P. M. Reconciling subjective memory complaints with objective memory performance in the menopausal transition. Menopause 19, 735\u2013741 (2012).","journal-title":"Menopause"},{"key":"1244_CR69","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/1047-2797(94)90099-X","volume":"4","author":"NE Avis","year":"1994","unstructured":"Avis, N. E., Brambilla, D., McKinlay, S. M. & Vass, K. A longitudinal analysis of the association between menopause and depression Results from the Massachusetts women\u2019s health study. Ann. Epidemiol. 4, 214\u2013220 (1994).","journal-title":"Ann. Epidemiol."},{"key":"1244_CR70","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.nurpra.2019.01.018","volume":"15","author":"E Bremer","year":"2019","unstructured":"Bremer, E., Jallo, N., Rodgers, B., Kinser, P. & Dautovich, N. Anxiety in Menopause: a distinctly different syndrome? J. Nurse Pract. 15, 374\u2013378 (2019).","journal-title":"J. Nurse Pract."},{"key":"1244_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.maturitas.2019.06.008","volume":"128","author":"M Caretto","year":"2019","unstructured":"Caretto, M., Giannini, A. & Simoncini, T. An integrated approach to diagnosing and managing sleep disorders in menopausal women. Maturitas 128, 1\u20133 (2019).","journal-title":"Maturitas"},{"key":"1244_CR72","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1097\/GME.0000000000000239","volume":"21","author":"L Lampio","year":"2014","unstructured":"Lampio, L. et al. Sleep in midlife women: effects of menopause, vasomotor symptoms, and depressive symptoms. Menopause 21, 1217\u20131224 (2014).","journal-title":"Menopause"},{"key":"1244_CR73","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1097\/gme.0b013e31816d815e","volume":"15","author":"PM Maki","year":"2008","unstructured":"Maki, P. M. et al. Objective hot flashes are negatively related to verbal memory performance in midlife women. Menopause 15, 848\u2013856 (2008).","journal-title":"Menopause"},{"key":"1244_CR74","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/GME.0000000000000481","volume":"23","author":"RC Thurston","year":"2016","unstructured":"Thurston, R. C., Aizenstein, H. J., Derby, C. A., Sejdi\u0107, E. & Maki, P. M. Menopausal hot flashes and white matter hyperintensities. Menopause 23, 27\u201332 (2016).","journal-title":"Menopause"},{"key":"1244_CR75","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1016\/S3050-5038(25)00121-9","volume":"1","author":"A Vall\u00e9e","year":"2025","unstructured":"Vall\u00e9e, A. & Ayoubi, J. From silence to science: the future of menopause research. Lancet Obstet. Gynaecol. Women\u2019s Health 1, e166\u2013e167 (2025).","journal-title":"Lancet Obstet. Gynaecol. Women\u2019s Health"},{"key":"1244_CR76","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ajhb.1081","volume":"13","author":"M Lock","year":"2001","unstructured":"Lock, M. & Kaufert, P. Menopause, local biologies, and cultures of aging. Am. J. Hum. Biol. 13, 494\u2013504 (2001).","journal-title":"Am. J. Hum. Biol."},{"key":"1244_CR77","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/humupd\/dmi018","volume":"11","author":"MK Melby","year":"2005","unstructured":"Melby, M. K., Lock, M. & Kaufert, P. Culture and symptom reporting at menopause. Hum. Reprod. Update 11, 495\u2013512 (2005).","journal-title":"Hum. Reprod. Update"},{"key":"1244_CR78","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/01.GME.0000161052.61139.74","volume":"12","author":"M Lock","year":"2005","unstructured":"Lock, M. Cross-cultural vasomotor symptom reporting: conceptual and methodological issues. Menopause 12, 239\u2013241 (2005).","journal-title":"Menopause"},{"key":"1244_CR79","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1017\/S0021932013000059","volume":"46","author":"RM Bove","year":"2014","unstructured":"Bove, R. M., Vala-Haynes, E. & Valeggia, C. Polygyny and women\u2019s health in rural Mali. J. Biosoc. Sci. 46, 66\u201389 (2014).","journal-title":"J. Biosoc. Sci."},{"key":"1244_CR80","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.socscimed.2008.09.045","volume":"68","author":"R Bove","year":"2009","unstructured":"Bove, R. & Valeggia, C. Polygyny and women\u2019s health in sub-Saharan Africa. Soc. Sci. Med. 68, 21\u201329 (2009).","journal-title":"Soc. Sci. Med."},{"key":"1244_CR81","first-page":"272","volume":"30","author":"C McGuinness","year":"2011","unstructured":"McGuinness, C. & Valeggia, C. La transici\u00f3n menop\u00e1usica en dos poblaciones \u00e9tnicamente diferentes de la ciudad de Formosa (The menopausal transition in two ethnically different populations of the city of Formosa). Encuentro de. Geohist. Regional 30, 272\u2013278 (2011).","journal-title":"Encuentro de. Geohist. Regional"},{"key":"1244_CR82","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/ije\/dyad085","volume":"52","author":"A Reeves","year":"2023","unstructured":"Reeves, A., Elliott, M. R., Karvonen-Gutierrez, C. A. & Harlow, S. D. Systematic exclusion at study commencement masks earlier menopause for Black women in the Study of Women\u2019s Health Across the Nation (SWAN). Int. J. Epidemiol. 52, 1612\u20131623 (2023).","journal-title":"Int. J. Epidemiol."},{"key":"1244_CR83","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/13557858.2022.2035691","volume":"28","author":"MJ Wong","year":"2023","unstructured":"Wong, M. J., Santos, C. & Thomas Tobin, C. S. Racial\/ethnic differences in social support and health among Asian American and non-Hispanic White midlife women: results from the study of women\u2019s health across the nation (SWAN). Ethn. Health 28, 182\u2013199 (2023).","journal-title":"Ethn. Health"},{"key":"1244_CR84","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40695-022-00073-y","volume":"8","author":"SD Harlow","year":"2022","unstructured":"Harlow, S. D. et al. Disparities in reproductive aging and midlife health between black and white women: the study of women\u2019s health across the nation (SWAN). Womens Midlife Health 8, 3 (2022).","journal-title":"Womens Midlife Health"},{"key":"1244_CR85","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1474-4422(24)00043-7","volume":"23","author":"R Bove","year":"2024","unstructured":"Bove, R., Silverman, H. & Valeggia, C. The postmenopausal brain: no silver bullet, but silver linings. Lancet Neurol. 23, 238\u2013239 (2024).","journal-title":"Lancet Neurol."},{"key":"1244_CR86","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/136218079900500408","volume":"5","author":"O Moscucci","year":"1999","unstructured":"Moscucci, O. Medicine, age and gender: the menopause in history. Br. Menopause Soc. J. 5, 149\u2013153 (1999).","journal-title":"Br. Menopause Soc. J."},{"key":"1244_CR87","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/GME.0000000000002028","volume":"29","author":"\u201cThe 2022 Hormone Therapy Position Statement of The North American Menopause Society\u201d Advisory Panel.","year":"2022","unstructured":"\u201cThe 2022 Hormone Therapy Position Statement of The North American Menopause Society\u201d Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 29, 767\u2013794 (2022).","journal-title":"Menopause"},{"key":"1244_CR88","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2024.3128","volume":"5","author":"L Yang","year":"2024","unstructured":"Yang, L. & Toriola, A. T. Menopausal hormone therapy use among postmenopausal women. JAMA Health Forum 5, e243128 (2024).","journal-title":"JAMA Health Forum"},{"key":"1244_CR89","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210228","volume":"104","author":"HE Silverman","year":"2025","unstructured":"Silverman, H. E. et al. Association of menopause with functional outcomes and disease biomarkers in women with multiple sclerosis. Neurology 104, e210228 (2025).","journal-title":"Neurology"},{"key":"1244_CR90","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1177\/1352458515606211","volume":"22","author":"R Bove","year":"2016","unstructured":"Bove, R. et al. Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort. Mult. Scler. 22, 935\u2013943 (2016).","journal-title":"Mult. Scler."},{"key":"1244_CR91","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1111\/ene.15299","volume":"29","author":"TI Kopp","year":"2022","unstructured":"Kopp, T. I., Lidegaard, \u00d8 & Magyari, M. Hormone therapy and disease activity in Danish women with multiple sclerosis: a population-based cohort study. Eur. J. Neurol. 29, 1753\u20131762 (2022).","journal-title":"Eur. J. Neurol."},{"key":"1244_CR92","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/d41586-025-00150-y","volume":"637","author":"No authors listed","year":"2025","unstructured":"Menopause research is globally underfunded. It\u2019s time to change that. Nature 637, 763 (2025).","journal-title":"Nature"},{"key":"1244_CR93","doi-asserted-by":"publisher","first-page":"101522","DOI":"10.1016\/j.jacadv.2024.101522","volume":"4","author":"SB Menezes","year":"2025","unstructured":"Menezes, S. B., Shenton, A. N., Hays, A. G. & Taub, C. C. Trends of representation of women in professional medical societal leadership in the United States and Europe. JACC Adv. 4, 101522 (2025).","journal-title":"JACC Adv."},{"key":"1244_CR94","unstructured":"Biden, J. R. Executive Order 14120 \u2014 advancing women\u2019s health research and innovation. The American Presidency Project https:\/\/www.presidency.ucsb.edu\/documents\/executive-order-14120-advancing-womens-health-research-and-innovation (2024)."},{"key":"1244_CR95","unstructured":"Bennett, J. The perimenopause gold rush. The Cut https:\/\/www.thecut.com\/article\/perimenopause-gold-rush-healthcare-companies-treatments.html (2024)."},{"key":"1244_CR96","unstructured":"Weitzner, R. Welcome to the menopause gold rush. New York Times https:\/\/www.nytimes.com\/2022\/12\/20\/style\/menopause-womens-health-goop.html (2022)."},{"key":"1244_CR97","unstructured":"Market analysis outlines startups disrupting menopause care, opportunities for investors. SJF Ventures https:\/\/sjfventures.com\/sjf-ventures-market-analysis-outlines-startups-disrupting-menopause-care-and-opportunities-for-investors\/ (2023)."},{"key":"1244_CR98","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/jcm13020428","volume":"13","author":"GH Jeon","year":"2024","unstructured":"Jeon, G. H. Insomnia in postmenopausal women: how to approach and treat it? J. Clin. Med. 13, 428 (2024).","journal-title":"J. Clin. Med."},{"key":"1244_CR99","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.maturitas.2015.04.017","volume":"81","author":"M Bruyneel","year":"2015","unstructured":"Bruyneel, M. Sleep disturbances in menopausal women: aetiology and practical aspects. Maturitas 81, 406\u2013409 (2015).","journal-title":"Maturitas"},{"key":"1244_CR100","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/GME.0000000000001020","volume":"25","author":"CC Gao","year":"2018","unstructured":"Gao, C. C. et al. Association of vasomotor symptoms and sleep apnea risk in midlife women. Menopause 25, 391\u2013398 (2018).","journal-title":"Menopause"},{"key":"1244_CR101","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/GME.0000000000001918","volume":"29","author":"HA Beydoun","year":"2022","unstructured":"Beydoun, H. A. et al. Association of sleep disturbance with Parkinson disease: evidence from the Women\u2019s Health Initiative. Menopause 29, 255\u2013263 (2022).","journal-title":"Menopause"},{"key":"1244_CR102","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/aje\/kwg155","volume":"158","author":"JT Bromberger","year":"2003","unstructured":"Bromberger, J. T. et al. Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am. J. Epidemiol. 158, 347\u2013356 (2003).","journal-title":"Am. J. Epidemiol."},{"key":"1244_CR103","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/GME.0000000000002339","volume":"31","author":"N Coslov","year":"2024","unstructured":"Coslov, N., Richardson, M. K. & Woods, N. F. \u2018Not feeling like myself\u2019 in perimenopause \u2014 what does it mean? Observations from the Women Living Better survey. Menopause 31, 390\u2013398 (2024).","journal-title":"Menopause"},{"key":"1244_CR104","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/GME.0000000000001988","volume":"29","author":"HM Kravitz","year":"2022","unstructured":"Kravitz, H. M. et al. Risk of high depressive symptoms after the final menstrual period: the Study of Women\u2019s Health Across the Nation (SWAN). Menopause 29, 805\u2013815 (2022).","journal-title":"Menopause"},{"key":"1244_CR105","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/gme.0b013e3182730599","volume":"20","author":"JT Bromberger","year":"2013","unstructured":"Bromberger, J. T. et al. Does risk for anxiety increase during the menopausal transition? Study of Women\u2019s Health Across the Nation. Menopause 20, 488\u2013495 (2013).","journal-title":"Menopause"},{"key":"1244_CR106","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1080\/13697137.2024.2380363","volume":"27","author":"VJ Wright","year":"2024","unstructured":"Wright, V. J., Schwartzman, J. D., Itinoche, R. & Wittstein, J. The musculoskeletal syndrome of menopause. Climacteric 27, 466\u2013472 (2024).","journal-title":"Climacteric"},{"key":"1244_CR107","doi-asserted-by":"publisher","first-page":"107844","DOI":"10.1016\/j.maturitas.2023.107844","volume":"178","author":"AJ Critchlow","year":"2023","unstructured":"Critchlow, A. J., Hiam, D., Williams, R., Scott, D. & Lamon, S. The role of estrogen in female skeletal muscle aging: a systematic review. Maturitas 178, 107844 (2023).","journal-title":"Maturitas"},{"key":"1244_CR108","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/GME.0000000000000944","volume":"25","author":"S Yoon","year":"2018","unstructured":"Yoon, S., Lee, D. H. & Bang, J. Perimenopausal arthralgia in the shoulder. Menopause 25, 98\u2013101 (2018).","journal-title":"Menopause"},{"key":"1244_CR109","volume":"12","author":"K Angelou","year":"2020","unstructured":"Angelou, K., Grigoriadis, T., Diakosavvas, M., Zacharakis, D. & Athanasiou, S. The Genitourinary Syndrome of Menopause: an overview of the recent data. Cureus 12, e7586 (2020).","journal-title":"Cureus"},{"key":"1244_CR110","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3390\/medicina60071059","volume":"60","author":"S Jankovic","year":"2024","unstructured":"Jankovic, S. et al. Understanding the benefits of CO2 laser treatment for vulvovaginal atrophy. Medicina 60, 1059 (2024).","journal-title":"Medicina"},{"key":"1244_CR111","first-page":"31","volume":"5","author":"BA Allio","year":"2016","unstructured":"Allio, B. A. & Peterson, A. C. Urodynamic and physiologic patterns associated with the common causes of neurogenic bladder in adults. Transl. Androl. Urol. 5, 31\u201338 (2016).","journal-title":"Transl. Androl. Urol."},{"key":"1244_CR112","doi-asserted-by":"publisher","first-page":"102378","DOI":"10.1016\/j.msard.2020.102378","volume":"45","author":"M Monti Bragadin","year":"2020","unstructured":"Monti Bragadin, M. et al. Lower urinary tract dysfunction in patients with multiple sclerosis: a post-void residual analysis of 501 cases. Mult. Scler. Relat. Disord. 45, 102378 (2020).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1244_CR113","doi-asserted-by":"publisher","first-page":"103793","DOI":"10.1016\/j.msard.2022.103793","volume":"62","author":"TB Kaplan","year":"2022","unstructured":"Kaplan, T. B. et al. Challenges to longitudinal characterization of lower urinary tract dysfunction in multiple sclerosis. Mult. Scler. Relat. Disord. 62, 103793 (2022).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1244_CR114","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jsbmb.2013.10.011","volume":"142","author":"BR Bhavnani","year":"2014","unstructured":"Bhavnani, B. R. & Stanczyk, F. Z. Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action. J. Steroid Biochem. Mol. Biol. 142, 16\u201329 (2014).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"1244_CR115","first-page":"147","volume":"3","author":"AM Egras","year":"2010","unstructured":"Egras, A. M. & Umland, E. M. The role of transdermal estrogen sprays and estradiol topical emulsion in the management of menopause-associated vasomotor symptoms. Int. J. Gen. Med. 3, 147\u2013151 (2010).","journal-title":"Int. J. Gen. Med."},{"key":"1244_CR116","unstructured":"Menopause: identification and management. National Institute for Health and Care Excellence https:\/\/www.nice.org.uk\/guidance\/ng23 (2024)."},{"key":"1244_CR117","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/jama.2013.278040","volume":"310","author":"JE Manson","year":"2013","unstructured":"Manson, J. E. et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women\u2019s Health Initiative randomized trials. J. Am. Med. Assoc 310, 1353\u20131368 (2013).","journal-title":"J. Am. Med. Assoc"},{"key":"1244_CR118","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1001\/jama.2024.6542","volume":"331","author":"JE Manson","year":"2024","unstructured":"Manson, J. E. et al. The Women\u2019s Health Initiative randomized trials and clinical practice: a review. J. Am. Med. Assoc. 331, 1748\u20131760 (2024).","journal-title":"J. Am. Med. Assoc."},{"key":"1244_CR119","doi-asserted-by":"publisher","first-page":"69","DOI":"10.6118\/jmm.20000","volume":"26","author":"Academic Committee of the Korean Society of Menopause","year":"2020","unstructured":"Academic Committee of the Korean Society of Menopauseet al. The 2020 menopausal hormone therapy guidelines. J. Menopausal Med. 26, 69\u201398 (2020).","journal-title":"J. Menopausal Med."},{"key":"1244_CR120","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.jogc.2021.08.003","volume":"43","author":"N Yuksel","year":"2021","unstructured":"Yuksel, N. et al. Guideline No. 422a: menopause: vasomotor symptoms, prescription therapeutic agents, complementary and alternative medicine, nutrition, and lifestyle. J. Obstet. Gynaecol. Can. 43, 1188\u20131204 (2021).","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"1244_CR121","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/20533691221104879","volume":"28","author":"H Hamoda","year":"2022","unstructured":"Hamoda, H. et al. Joint position statement by the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on best practice recommendations for the care of women experiencing the menopause. Post. Reprod. Health 28, 123\u2013125 (2022).","journal-title":"Post. Reprod. Health"},{"key":"1244_CR122","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5853\/jos.2022.03468","volume":"25","author":"CW Yoon","year":"2023","unstructured":"Yoon, C. W. & Bushnell, C. D. Stroke in women: a review focused on epidemiology, risk factors, and outcomes. J. Stroke 25, 2\u201315 (2023).","journal-title":"J. Stroke"},{"key":"1244_CR123","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/STROKEAHA.117.018415","volume":"49","author":"SL Demel","year":"2018","unstructured":"Demel, S. L., Kittner, S., Ley, S. H., McDermott, M. & Rexrode, K. M. Stroke risk factors unique to women. Stroke 49, 518\u2013523 (2018).","journal-title":"Stroke"},{"key":"1244_CR124","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/epi.17842","volume":"65","author":"M Alshakhouri","year":"2024","unstructured":"Alshakhouri, M., Sharpe, C., Bergin, P. & Sumner, R. L. Female sex steroids and epilepsy: part 1. A review of reciprocal changes in reproductive systems, cycles, and seizures. Epilepsia 65, 556\u2013568 (2024).","journal-title":"Epilepsia"},{"key":"1244_CR125","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1111\/ene.15916","volume":"30","author":"V Carvalho","year":"2023","unstructured":"Carvalho, V. et al. Sex steroid hormones and epilepsy: effects of hormonal replacement therapy on seizure frequency of postmenopausal women with epilepsy-A systematic review. Eur. J. Neurol. 30, 2884\u20132898 (2023).","journal-title":"Eur. J. Neurol."},{"key":"1244_CR126","volume":"17","author":"H Kolomar","year":"2025","unstructured":"Kolomar, H. et al. A comprehensive review on the influence of menstrual cycle and pregnancy on epileptic seizures. Cureus 17, e80387 (2025).","journal-title":"Cureus"},{"key":"1244_CR127","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00737-022-01251-7","volume":"25","author":"CK Klatter","year":"2022","unstructured":"Klatter, C. K., van Ravesteyn, L. M. & Stekelenburg, J. Is collaborative care a key component for treating pregnant women with psychiatric symptoms (and additional psychosocial problems)? A systematic review. Arch. Womens Ment. Health 25, 1029\u20131039 (2022).","journal-title":"Arch. Womens Ment. Health"},{"key":"1244_CR128","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2147\/PPA.S165238","volume":"12","author":"M Lu","year":"2018","unstructured":"Lu, M. et al. Impact of multidisciplinary collaborative pharmaceutical care on knowledge, adherence, and efficacy of hormone therapy in climacteric women. Patient Prefer. Adherence 12, 1273\u20131278 (2018).","journal-title":"Patient Prefer. Adherence"},{"key":"1244_CR129","doi-asserted-by":"publisher","first-page":"554375","DOI":"10.3389\/fneur.2021.554375","volume":"12","author":"R Bove","year":"2021","unstructured":"Bove, R. et al. Effects of menopause in women with multiple sclerosis: an evidence-based review. Front. Neurol. 12, 554375 (2021).","journal-title":"Front. Neurol."},{"key":"1244_CR130","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1007\/s00415-023-12152-9","volume":"271","author":"L Lorefice","year":"2024","unstructured":"Lorefice, L. et al. Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS Registry. J. Neurol. 271, 1630\u20131637 (2024).","journal-title":"J. Neurol."},{"key":"1244_CR131","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2024.3062","author":"LH Hua","year":"2024","unstructured":"Hua, L. H. et al. Differential diagnosis of suspected multiple sclerosis in pediatric and late-onset populations: a review. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2024.3062 (2024).","journal-title":"JAMA Neurol."},{"key":"1244_CR132","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1177\/1352458512438236","volume":"18","author":"RM Bove","year":"2012","unstructured":"Bove, R. M. et al. Effect of gender on late-onset multiple sclerosis. Mult. Scler. 18, 1472\u20131479 (2012).","journal-title":"Mult. Scler."},{"key":"1244_CR133","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.2020.26858","volume":"325","author":"MP McGinley","year":"2021","unstructured":"McGinley, M. P., Goldschmidt, C. H. & Rae-Grant, A. D. Diagnosis and treatment of multiple sclerosis: a review. J. Am. Med. Assoc. 325, 765\u2013779 (2021).","journal-title":"J. Am. Med. Assoc."},{"key":"1244_CR134","unstructured":"Johnston, R. B. Jr & Joy, J. E. (eds.) Current Status and Strategies for the Future Ch. 3 (National Academies Press, 2001)."},{"key":"1244_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02344-z","volume":"21","author":"S Gustavsen","year":"2021","unstructured":"Gustavsen, S. et al. The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey. BMC Neurol. 21, 317 (2021).","journal-title":"BMC Neurol."},{"key":"1244_CR136","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.msard.2016.06.015","volume":"9","author":"R Bove","year":"2016","unstructured":"Bove, R., Vaughan, T., Chitnis, T., Wicks, P. & De Jager, P. L. Women\u2019s experiences of menopause in an online MS cohort: a case series. Mult. Scler. Relat. Disord. 9, 56\u201359 (2016).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1244_CR137","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1212\/01.CON.0000433287.30715.07","volume":"19","author":"AD Rae-Grant","year":"2013","unstructured":"Rae-Grant, A. D. Unusual symptoms and syndromes in multiple sclerosis. Continuum 19, 992\u20131006 (2013).","journal-title":"Continuum"},{"key":"1244_CR138","doi-asserted-by":"publisher","first-page":"104952","DOI":"10.1016\/j.msard.2023.104952","volume":"79","author":"J Lechner-Scott","year":"2023","unstructured":"Lechner-Scott, J. et al. Managing cognitive impairment and its impact in multiple sclerosis: an Australian multidisciplinary perspective. Mult. Scler. Relat. Disord. 79, 104952 (2023).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1244_CR139","doi-asserted-by":"publisher","first-page":"fcab023","DOI":"10.1093\/braincomms\/fcab023","volume":"3","author":"M Cercignani","year":"2021","unstructured":"Cercignani, M. et al. Cognitive fatigue in multiple sclerosis is associated with alterations in the functional connectivity of monoamine circuits. Brain Commun. 3, fcab023 (2021).","journal-title":"Brain Commun."},{"key":"1244_CR140","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-025-04106-7","volume":"25","author":"A Beczek","year":"2025","unstructured":"Beczek, A. et al. Experiences and challenges of people with multiple sclerosis and low attendance to clinical follow-up: a qualitative study. BMC Neurol. 25, 107 (2025).","journal-title":"BMC Neurol."},{"key":"1244_CR141","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00415-013-7131-8","volume":"261","author":"R Bove","year":"2014","unstructured":"Bove, R., Chitnis, T. & Houtchens, M. Menopause in multiple sclerosis: therapeutic considerations. J. Neurol. 261, 1257\u20131268 (2014).","journal-title":"J. Neurol."},{"key":"1244_CR142","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.msard.2014.11.009","volume":"4","author":"R Bove","year":"2015","unstructured":"Bove, R. et al. Patients report worse MS symptoms after menopause: findings from an online cohort. Mult. Scler. Relat. Disord. 4, 18\u201324 (2015).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1244_CR143","doi-asserted-by":"publisher","first-page":"103747","DOI":"10.1016\/j.msard.2022.103747","volume":"61","author":"R Bove","year":"2022","unstructured":"Bove, R. et al. A hormonal therapy for menopausal women with MS: A phase Ib\/IIa randomized controlled trial. Mult. Scler. Relat. Disord. 61, 103747 (2022).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1244_CR144","doi-asserted-by":"publisher","first-page":"104098","DOI":"10.1016\/j.msard.2022.104098","volume":"67","author":"L Juutinen","year":"2022","unstructured":"Juutinen, L., Ahinko, K., Tinkanen, H., Rosti-Otaj\u00e4rvi, E. & Sumelahti, M. L. Menopausal symptoms and hormone therapy in women with multiple sclerosis: a baseline-controlled study. Mult. Scler. Relat. Disord. 67, 104098 (2022).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1244_CR145","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10072-015-2155-8","volume":"36","author":"G Allais","year":"2015","unstructured":"Allais, G., Chiarle, G., Bergandi, F. & Benedetto, C. Migraine in perimenopausal women. Neurol. Sci. 36, 79\u201383 (2015).","journal-title":"Neurol. Sci."},{"key":"1244_CR146","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S1474-4422(16)30293-9","volume":"16","author":"KG Vetvik","year":"2017","unstructured":"Vetvik, K. G. & MacGregor, E. A. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 16, 76\u201387 (2017).","journal-title":"Lancet Neurol."},{"key":"1244_CR147","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/GME.0000000000001635","volume":"28","author":"C Bernstein","year":"2020","unstructured":"Bernstein, C. & O\u2019Neal, M. A. Migraine and menopause \u2014 a narrative review. Menopause 28, 96\u2013101 (2020).","journal-title":"Menopause"},{"key":"1244_CR148","doi-asserted-by":"publisher","first-page":"e935","DOI":"10.1212\/WNL.0000000000200782","volume":"99","author":"V Lohner","year":"2022","unstructured":"Lohner, V. et al. Relation between sex, menopause, and white matter hyperintensities: the rhineland study. Neurology 99, e935\u2013e943 (2022).","journal-title":"Neurology"},{"key":"1244_CR149","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","volume":"24","author":"X Montalban","year":"2025","unstructured":"Montalban, X. et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 24, 850\u2013865 (2025).","journal-title":"Lancet Neurol."},{"key":"1244_CR150","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.1007\/s10072-022-06185-7","volume":"43","author":"M Pengo","year":"2022","unstructured":"Pengo, M. et al. Sex influences clinical phenotype in frontotemporal dementia. Neurol. Sci. 43, 5281\u20135287 (2022).","journal-title":"Neurol. Sci."},{"key":"1244_CR151","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/brain\/awab365","volume":"145","author":"MS Barker","year":"2022","unstructured":"Barker, M. S. et al. Proposed research criteria for prodromal behavioural variant frontotemporal dementia. Brain 145, 1079\u20131097 (2022).","journal-title":"Brain"},{"key":"1244_CR152","volume":"14","author":"K Fatima","year":"2022","unstructured":"Fatima, K., Mehendale, A. M. & Reddy, H. Young-onset dementia and neurodegenerative disorders of the young with an emphasis on clinical manifestations. Cureus 14, e30025 (2022).","journal-title":"Cureus"},{"key":"1244_CR153","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1001\/jamaneurol.2018.3057","volume":"76","author":"B Zeydan","year":"2019","unstructured":"Zeydan, B. et al. Association of bilateral salpingo-oophorectomy before menopause onset with medial temporal lobe neurodegeneration. JAMA Neurol. 76, 95\u2013100 (2019).","journal-title":"JAMA Neurol."},{"key":"1244_CR154","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/GME.0000000000001415","volume":"27","author":"SK Laughlin-Tommaso","year":"2020","unstructured":"Laughlin-Tommaso, S. K. et al. Long-term risk of de novo mental health conditions after hysterectomy with ovarian conservation: a cohort study. Menopause 27, 33\u201342 (2020).","journal-title":"Menopause"},{"key":"1244_CR155","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1212\/WNL.0000000000000033","volume":"82","author":"R Bove","year":"2014","unstructured":"Bove, R. et al. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology 82, 222\u2013229 (2014).","journal-title":"Neurology"},{"key":"1244_CR156","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199073","volume":"13","author":"RM Bove","year":"2018","unstructured":"Bove, R. M. et al. Reproductive period and epigenetic modifications of the oxidative phosphorylation pathway in the human prefrontal cortex. PLoS ONE 13, e0199073 (2018).","journal-title":"PLoS ONE"},{"key":"1244_CR157","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/mds.28563","volume":"36","author":"M Canonico","year":"2021","unstructured":"Canonico, M. et al. Increased risk of Parkinson\u2019s disease in women after bilateral oophorectomy. Mov. Disord. 36, 1696\u20131700 (2021).","journal-title":"Mov. Disord."},{"key":"1244_CR158","doi-asserted-by":"publisher","first-page":"106025","DOI":"10.1016\/j.parkreldis.2024.106025","volume":"121","author":"A Ali","year":"2024","unstructured":"Ali, A. et al. Association of bilateral oophorectomy with incidence of Parkinson\u2019s disease: a systematic review and meta-analysis. Parkinsonism Relat. Disord. 121, 106025 (2024).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1244_CR159","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3389\/fneur.2017.00397","volume":"8","author":"D Frentzel","year":"2017","unstructured":"Frentzel, D. et al. Increase of reproductive life span delays age of onset of Parkinson\u2019s disease. Front. Neurol. 8, 397 (2017).","journal-title":"Front. Neurol."},{"key":"1244_CR160","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/mds.28760","volume":"36","author":"CDJ Kusters","year":"2021","unstructured":"Kusters, C. D. J. et al. Increased menopausal age reduces the risk of Parkinson\u2019s disease: a mendelian randomization approach. Mov. Disord. 36, 2264\u20132272 (2021).","journal-title":"Mov. Disord."},{"key":"1244_CR161","doi-asserted-by":"publisher","first-page":"5695","DOI":"10.1002\/alz.13844","volume":"20","author":"EM Arenaza-Urquijo","year":"2024","unstructured":"Arenaza-Urquijo, E. M. et al. Sex and gender differences in cognitive resilience to aging and Alzheimer\u2019s disease. Alzheimers Dement. 20, 5695\u20135719 (2024).","journal-title":"Alzheimers Dement."},{"key":"1244_CR162","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.brainres.2010.10.031","volume":"1379","author":"WA Rocca","year":"2011","unstructured":"Rocca, W. A., Grossardt, B. R. & Shuster, L. T. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res. 1379, 188\u2013198 (2011).","journal-title":"Brain Res."},{"key":"1244_CR163","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1002\/alz.13575","volume":"20","author":"AM Stickel","year":"2024","unstructured":"Stickel, A. M. et al. Connections between reproductive health and cognitive aging among women enrolled in the HCHS\/SOL and SOL-INCA. Alzheimers Dement. 20, 1944\u20131957 (2024).","journal-title":"Alzheimers Dement."},{"key":"1244_CR164","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/alz.13454","volume":"20","author":"R Saloner","year":"2024","unstructured":"Saloner, R. et al. Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults. Alzheimers Dement. 20, 376\u2013387 (2024).","journal-title":"Alzheimers Dement."},{"key":"1244_CR165","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.04.003","volume":"105","author":"L Edwards","year":"2021","unstructured":"Edwards, L. et al. Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer\u2019s continuum: greater tau-PET retention in females. Neurobiol. Aging 105, 86\u201398 (2021).","journal-title":"Neurobiol. Aging"},{"key":"1244_CR166","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1093\/brain\/awac257","volume":"145","author":"KB Casaletto","year":"2022","unstructured":"Casaletto, K. B. et al. Sex-specific effects of microglial activation on Alzheimer\u2019s disease proteinopathy in older adults. Brain 145, 3536\u20133545 (2022).","journal-title":"Brain"},{"key":"1244_CR167","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ana.26382","volume":"92","author":"RF Buckley","year":"2022","unstructured":"Buckley, R. F. et al. Menopause status moderates sex differences in tau burden: a framingham pet study. Ann. Neurol. 92, 11\u201322 (2022).","journal-title":"Ann. Neurol."},{"key":"1244_CR168","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jamaneurol.2023.0455","volume":"80","author":"GT Coughlan","year":"2023","unstructured":"Coughlan, G. T. et al. Association of age at menopause and hormone therapy use with tau and \u03b2-amyloid positron emission tomography. JAMA Neurol. 80, 462\u2013473 (2023).","journal-title":"JAMA Neurol."},{"key":"1244_CR169","doi-asserted-by":"publisher","first-page":"148079","DOI":"10.1016\/j.brainres.2022.148079","volume":"1795","author":"AJ Costa","year":"2022","unstructured":"Costa, A. J. et al. Membrane estrogen receptor ER\u03b1 activation improves tau clearance via autophagy induction in a tauopathy cell model. Brain Res. 1795, 148079 (2022).","journal-title":"Brain Res."},{"key":"1244_CR170","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1111\/bph.14585","volume":"176","author":"JM Perez Ortiz","year":"2019","unstructured":"Perez Ortiz, J. M. & Swerdlow, R. H. Mitochondrial dysfunction in Alzheimer\u2019s disease: role in pathogenesis and novel therapeutic opportunities. Br. J. Pharmacol. 176, 3489\u20133507 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"1244_CR171","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/B978-0-12-394816-8.00010-6","volume":"64","author":"J Yao","year":"2012","unstructured":"Yao, J. & Brinton, R. D. Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer\u2019s disease. Adv. Pharmacol. 64, 327\u2013371 (2012).","journal-title":"Adv. Pharmacol."},{"key":"1244_CR172","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fnagi.2018.00124","volume":"10","author":"I Lejri","year":"2018","unstructured":"Lejri, I., Grimm, A. & Eckert, A. Mitochondria, estrogen and female brain aging. Front. Aging Neurosci. 10, 124 (2018).","journal-title":"Front. Aging Neurosci."},{"key":"1244_CR173","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.18632\/aging.101538","volume":"10","author":"CM Evola","year":"2018","unstructured":"Evola, C. M., Hudson, T. L., Huang, L., Corbett, A. M. & Mayes, D. A. Gender- and region-specific changes in estrogen signaling in aging rat brain mitochondria. Aging 10, 2148\u20132169 (2018).","journal-title":"Aging"},{"key":"1244_CR174","doi-asserted-by":"publisher","first-page":"102033","DOI":"10.1016\/j.eclinm.2023.102033","volume":"60","author":"H Liao","year":"2023","unstructured":"Liao, H. et al. Association of earlier age at menopause with risk of incident dementia, brain structural indices and the potential mediators: a prospective community-based cohort study. eClinicalMedicine 60, 102033 (2023).","journal-title":"eClinicalMedicine"},{"key":"1244_CR175","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209298","volume":"102","author":"M Wood Alexander","year":"2024","unstructured":"Wood Alexander, M. et al. Associations between age at menopause, vascular risk, and 3-year cognitive change in the Canadian Longitudinal Study on Aging. Neurology 102, e209298 (2024).","journal-title":"Neurology"},{"key":"1244_CR176","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jclinepi.2021.08.001","volume":"142","author":"JC Digitale","year":"2022","unstructured":"Digitale, J. C., Martin, J. N. & Glymour, M. M. Tutorial on directed acyclic graphs. J. Clin. Epidemiol. 142, 264\u2013267 (2022).","journal-title":"J. Clin. Epidemiol."},{"key":"1244_CR177","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.31448","volume":"4","author":"WA Rocca","year":"2021","unstructured":"Rocca, W. A. et al. Association of premenopausal bilateral oophorectomy with cognitive performance and risk of mild cognitive impairment. JAMA Netw. Open 4, e2131448 (2021).","journal-title":"JAMA Netw. Open"},{"key":"1244_CR178","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen, R. C. et al. Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology 74, 201\u2013209 (2010).","journal-title":"Neurology"},{"key":"1244_CR179","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"1244_CR180","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70176","volume":"21","author":"WS Kremen","year":"2025","unstructured":"Kremen, W. S. et al. A lifespan perspective on cognitive reserve and risk for dementia. Alzheimers Dement. 21, e70176 (2025).","journal-title":"Alzheimers Dement."},{"key":"1244_CR181","volume":"17","author":"P Iso-Markku","year":"2025","unstructured":"Iso-Markku, P. et al. Relationships among young adult general cognitive ability, midlife physical activity, and early late-life cognitive functioning: a four-decade longitudinal cohort study in men. Alzheimers Dement. 17, e70169 (2025).","journal-title":"Alzheimers Dement."},{"key":"1244_CR182","doi-asserted-by":"publisher","first-page":"100724","DOI":"10.1016\/j.lanhl.2025.100724","volume":"6","author":"T Canning","year":"2025","unstructured":"Canning, T. et al. Associations between life course exposure to ambient air pollution with cognition and later-life brain structure: a population-based study of the 1946 British Birth Cohort. Lancet Healthy Longev. 6, 100724 (2025).","journal-title":"Lancet Healthy Longev."},{"key":"1244_CR183","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1093\/humrep\/dead176","volume":"38","author":"G Fan","year":"2023","unstructured":"Fan, G. et al. Association between female-specific reproductive factors and leukocyte telomere length. Hum. Reprod. 38, 2239\u20132246 (2023).","journal-title":"Hum. Reprod."},{"key":"1244_CR184","doi-asserted-by":"publisher","first-page":"1429514","DOI":"10.3389\/fendo.2024.1429514","volume":"15","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Exploring the causal association between epigenetic clocks and menopause age: insights from a bidirectional Mendelian randomization study. Front. Endocrinol. 15, 1429514 (2024).","journal-title":"Front. Endocrinol."},{"key":"1244_CR185","doi-asserted-by":"publisher","first-page":"9327","DOI":"10.1073\/pnas.1604558113","volume":"113","author":"ME Levine","year":"2016","unstructured":"Levine, M. E. et al. Menopause accelerates biological aging. Proc. Natl Acad. Sci. USA 113, 9327\u20139332 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1244_CR186","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1161\/STROKEAHA.120.030558","volume":"52","author":"SJGC Welten","year":"2021","unstructured":"Welten, S. J. G. C., Onland-Moret, N. C., Boer, J. M. A., Verschuren, W. M. M. & van der Schouw, Y. T. Age at menopause and risk of ischemic and hemorrhagic stroke. Stroke 52, 2583\u20132591 (2021).","journal-title":"Stroke"},{"key":"1244_CR187","doi-asserted-by":"publisher","first-page":"1131251","DOI":"10.3389\/fcvm.2023.1131251","volume":"10","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. The risk of long-term cardiometabolic disease in women with premature or early menopause: a systematic review and meta-analysis. Front. Cardiovasc. Med. 10, 1131251 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"1244_CR188","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1001\/jamacardio.2016.2415","volume":"1","author":"T Muka","year":"2016","unstructured":"Muka, T. et al. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis. JAMA Cardiol. 1, 767\u2013776 (2016).","journal-title":"JAMA Cardiol."},{"key":"1244_CR189","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02269-2","volume":"12","author":"Z-T Wang","year":"2022","unstructured":"Wang, Z.-T. et al. Modified dementia risk score as a tool for the prediction of dementia: a prospective cohort study of 239745 participants. Transl. Psychiatry 12, 509 (2022).","journal-title":"Transl. Psychiatry"},{"key":"1244_CR190","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14464","author":"CS Dintica","year":"2024","unstructured":"Dintica, C. S., Jiang, X., Launer, L. J., Bryan, R. N. & Yaffe, K. Life\u2019s Essential 8 and midlife trajectories in cognition and brain health: The CARDIA study. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.14464 (2024).","journal-title":"Alzheimers Dement."},{"key":"1244_CR191","doi-asserted-by":"publisher","first-page":"1291020","DOI":"10.3389\/fneur.2023.1291020","volume":"14","author":"SD Singh","year":"2023","unstructured":"Singh, S. D. et al. The predictive validity of a brain care score for dementia and stroke: data from the UK Biobank cohort. Front. Neurol. 14, 1291020 (2023).","journal-title":"Front. Neurol."},{"key":"1244_CR192","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1097\/GME.0000000000002549","volume":"32","author":"Z Wang","year":"2025","unstructured":"Wang, Z. et al. Prospective associations of American Heart Association Life\u2019s Essential 8 with subclinical measures of vascular health, cardiovascular disease events, and all-cause mortality in women traversing menopause: the study of women\u2019s health across the nation study. Menopause 32, 758\u2013768 (2025).","journal-title":"Menopause"},{"key":"1244_CR193","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/GME.0000000000002107","volume":"30","author":"S Witkowski","year":"2023","unstructured":"Witkowski, S., Evard, R., Rickson, J. J., White, Q. & Sievert, L. L. Physical activity and exercise for hot flashes: trigger or treatment. Menopause 30, 218\u2013224 (2023).","journal-title":"Menopause"},{"key":"1244_CR194","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/ajhb.20834","volume":"21","author":"WA Romani","year":"2009","unstructured":"Romani, W. A., Gallicchio, L. & Flaws, J. A. The association between physical activity and hot flash severity, frequency, and duration in mid-life women. Am. J. Hum. Biol. 21, 127\u2013129 (2009).","journal-title":"Am. J. Hum. Biol."},{"key":"1244_CR195","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/CIRCRESAHA.121.319915","volume":"130","author":"KM Rexrode","year":"2022","unstructured":"Rexrode, K. M. et al. The impact of sex and gender on stroke. Circ. Res. 130, 512\u2013528 (2022).","journal-title":"Circ. Res."},{"key":"1244_CR196","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.5077","volume":"4","author":"A de Havenon","year":"2021","unstructured":"de Havenon, A. et al. Association of preeclampsia with incident stroke in later life among women in the framingham heart study. JAMA Netw. Open. 4, e215077 (2021).","journal-title":"JAMA Netw. Open."},{"key":"1244_CR197","doi-asserted-by":"publisher","first-page":"107936","DOI":"10.1016\/j.maturitas.2024.107936","volume":"185","author":"FR P\u00e9rez-L\u00f3pez","year":"2024","unstructured":"P\u00e9rez-L\u00f3pez, F. R., Rodr\u00edguez, I. & Garc\u00eda-Alfaro, P. The use of the directed acyclic graph to disentangle confounding variables from causal factors in observational studies. Maturitas 185, 107936 (2024).","journal-title":"Maturitas"},{"key":"1244_CR198","doi-asserted-by":"publisher","first-page":"1158001","DOI":"10.3389\/fnagi.2023.1158001","volume":"15","author":"NZ Ramli","year":"2023","unstructured":"Ramli, N. Z. et al. Brain volumetric changes in menopausal women and its association with cognitive function: a structured review. Front. Aging Neurosci. 15, 1158001 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"1244_CR199","doi-asserted-by":"publisher","first-page":"e2328","DOI":"10.1212\/WNL.0000000000012941","volume":"97","author":"E Schelbaum","year":"2021","unstructured":"Schelbaum, E. et al. Association of reproductive history with brain MRI biomarkers of dementia risk in midlife. Neurology 97, e2328\u2013e2339 (2021).","journal-title":"Neurology"},{"key":"1244_CR200","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.3390\/jcm11206163","volume":"11","author":"R Ou","year":"2022","unstructured":"Ou, R. et al. Reproductive lifespan and motor progression of Parkinson\u2019s disease. J. Clin. Med. 11, 6163 (2022).","journal-title":"J. Clin. Med."},{"key":"1244_CR201","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1089\/jwh.2023.1134","volume":"33","author":"EE Adam","year":"2024","unstructured":"Adam, E. E., White, M. C., Townsend, J. S. & Stewart, S. L. Bilateral oophorectomy prevalence among US women. J. Womens Health 33, 1457\u20131463 (2024).","journal-title":"J. Womens Health"},{"key":"1244_CR202","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck, T. R., Kauff, N. D. & Domchek, S. M. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J. Natl Cancer Inst. 101, 80\u201387 (2009).","journal-title":"J. Natl Cancer Inst."},{"key":"1244_CR203","first-page":"Cd012464","volume":"8","author":"GU Eleje","year":"2018","unstructured":"Eleje, G. U. et al. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations. Cochrane Database Syst. Rev. 8, Cd012464 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1244_CR204","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2020.04.019","volume":"94","author":"NJ Gervais","year":"2020","unstructured":"Gervais, N. J. et al. Cognitive markers of dementia risk in middle-aged women with bilateral salpingo-oophorectomy prior to menopause. Neurobiol. Aging 94, 1\u20136 (2020).","journal-title":"Neurobiol. Aging"},{"key":"1244_CR205","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/medicina55080482","volume":"55","author":"C Seco\u0219an","year":"2019","unstructured":"Seco\u0219an, C. et al. Surgically induced menopause-A practical review of literature. Medicina 55, 482 (2019).","journal-title":"Medicina"},{"key":"1244_CR206","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/GME.0000000000002555","volume":"32","author":"JK Kim","year":"2025","unstructured":"Kim, J. K. & Crimmins, E. M. Early menopause, hysterectomy, and biological aging: health and retirement study. Menopause 32, 692\u2013701 (2025).","journal-title":"Menopause"},{"key":"1244_CR207","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.yfrne.2009.05.006","volume":"30","author":"JL Do Rego","year":"2009","unstructured":"Do Rego, J. L. et al. Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides. Front. Neuroendocrinol. 30, 259\u2013301 (2009).","journal-title":"Front. Neuroendocrinol."},{"key":"1244_CR208","doi-asserted-by":"publisher","first-page":"111672","DOI":"10.1016\/j.celrep.2022.111672","volume":"41","author":"R Qureshi","year":"2022","unstructured":"Qureshi, R. et al. Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER\u2009+\u2009breast cancer metastasis. Cell Rep. 41, 111672 (2022).","journal-title":"Cell Rep."},{"key":"1244_CR209","first-page":"2229","volume":"9","author":"Y Miyoshi","year":"2003","unstructured":"Miyoshi, Y., Tanji, Y., Taguchi, T., Tamaki, Y. & Noguchi, S. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women. Clin. Cancer Res. 9, 2229\u20132233 (2003).","journal-title":"Clin. Cancer Res."},{"key":"1244_CR210","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/00019442-200502000-00008","volume":"13","author":"OP Almeida","year":"2005","unstructured":"Almeida, O. P., Lautenschlager, N., Vasikaram, S., Leedman, P. & Flicker, L. Association between physiological serum concentration of estrogen and the mental health of community-dwelling postmenopausal women age 70 years and over. Am. J. Geriatr. Psychiatry 13, 142\u2013149 (2005).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"1244_CR211","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/cercor\/bhs125","volume":"23","author":"TV Nguyen","year":"2013","unstructured":"Nguyen, T. V. et al. Testosterone-related cortical maturation across childhood and adolescence. Cereb. Cortex 23, 1424\u20131432 (2013).","journal-title":"Cereb. Cortex"},{"key":"1244_CR212","doi-asserted-by":"publisher","first-page":"ENEURO.0468","DOI":"10.1523\/ENEURO.0468-19.2020","volume":"7","author":"S Yagi","year":"2020","unstructured":"Yagi, S. et al. Sex differences in maturation and attrition of adult neurogenesis in the hippocampus. eNeuro 7, ENEURO.0468\u201319 (2020).","journal-title":"eNeuro"},{"key":"1244_CR213","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.dcn.2022.101133","volume":"56","author":"CE Page","year":"2022","unstructured":"Page, C. E., Biagiotti, S. W., Alderman, P. J. & Sorrells, S. F. Immature excitatory neurons in the amygdala come of age during puberty. Dev. Cogn. Neurosci. 56, 101133 (2022).","journal-title":"Dev. Cogn. Neurosci."},{"key":"1244_CR214","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1210\/en.2019-00114","volume":"160","author":"P Duarte-Guterman","year":"2019","unstructured":"Duarte-Guterman, P. et al. Androgens enhance adult hippocampal neurogenesis in males but not females in an age-dependent manner. Endocrinology 160, 2128\u20132136 (2019).","journal-title":"Endocrinology"},{"key":"1244_CR215","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1172\/JCI125755","volume":"129","author":"SR Hammes","year":"2019","unstructured":"Hammes, S. R. & Levin, E. R. Impact of estrogens in males and androgens in females. J. Clin. Invest. 129, 1818\u20131826 (2019).","journal-title":"J. Clin. Invest."},{"key":"1244_CR216","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.maturitas.2009.04.008","volume":"63","author":"JM Krapf","year":"2009","unstructured":"Krapf, J. M. & Simon, J. A. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. Maturitas 63, 213\u2013219 (2009).","journal-title":"Maturitas"},{"key":"1244_CR217","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.3390\/jcm12206501","volume":"12","author":"L Kogler","year":"2023","unstructured":"Kogler, L. et al. Testosterone and the Amygdala\u2019s functional connectivity in women and men. J. Clin. Med. 12, 6501 (2023).","journal-title":"J. Clin. Med."},{"key":"1244_CR218","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00276-015-1547-z","volume":"38","author":"GW Kim","year":"2016","unstructured":"Kim, G. W., Kim, S. K. & Jeong, G. W. Neural activation-based sexual orientation and its correlation with free testosterone level in postoperative female-to-male transsexuals: preliminary study with 3.0-T fMRI. Surg. Radiol. Anat. 38, 245\u2013252 (2016).","journal-title":"Surg. Radiol. Anat."},{"key":"1244_CR219","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/01.gme.0000188737.46746.cd","volume":"13","author":"JS Archer","year":"2006","unstructured":"Archer, J. S., Love-Geffen, T. E., Herbst-Damm, K. L., Swinney, D. A. & Chang, J. R. Effect of estradiol versus estradiol and testosterone on brain-activation patterns in postmenopausal women. Menopause 13, 528\u2013537 (2006).","journal-title":"Menopause"},{"key":"1244_CR220","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/j.1532-5415.1999.tb07427.x","volume":"47","author":"E Barrett-Connor","year":"1999","unstructured":"Barrett-Connor, E. & Goodman-Gruen, D. Cognitive function and endogenous sex hormones in older women. J. Am. Geriatr. Soc. 47, 1289\u20131293 (1999).","journal-title":"J. Am. Geriatr. Soc."},{"key":"1244_CR221","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/13697137.2024.2354725","volume":"27","author":"M Henze","year":"2024","unstructured":"Henze, M. & Stuckey, B. G. A. Endocrine consequences of breast cancer therapy and survivorship. Climacteric 27, 333\u2013339 (2024).","journal-title":"Climacteric"},{"key":"1244_CR222","unstructured":"Hormone therapy for breast cancer. National Cancer Institute https:\/\/www.cancer.gov\/types\/breast\/breast-hormone-therapy-fact-sheet (2022)."},{"key":"1244_CR223","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/NEJMoa1803164","volume":"379","author":"PA Francis","year":"2018","unstructured":"Francis, P. A. et al. Tailoring adjuvant endocrine therapy for premenopausal breast cancer. N. Engl. J. Med. 379, 122\u2013137 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1244_CR224","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/jama.2025.2975","volume":"334","author":"S As-Sanie","year":"2025","unstructured":"As-Sanie, S. et al. Endometriosis: a review. J. Am. Med. Assoc. 334, 64\u201378 (2025).","journal-title":"J. Am. Med. Assoc."},{"key":"1244_CR225","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11864-024-01190-8","volume":"25","author":"C Molinelli","year":"2024","unstructured":"Molinelli, C. et al. Ovarian suppression: early menopause and late effects. Curr. Treat. Options Oncol. 25, 523\u2013542 (2024).","journal-title":"Curr. Treat. Options Oncol."},{"key":"1244_CR226","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1002\/cam4.5175","volume":"12","author":"F Kara","year":"2023","unstructured":"Kara, F. et al. Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration. Cancer Med. 12, 2805\u20132817 (2023).","journal-title":"Cancer Med."},{"key":"1244_CR227","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10549-017-4627-4","volume":"168","author":"EA Underwood","year":"2018","unstructured":"Underwood, E. A. et al. Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis. Breast Cancer Res. Treat. 168, 299\u2013310 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"1244_CR228","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fphar.2017.00612","volume":"8","author":"KF Liao","year":"2017","unstructured":"Liao, K. F., Lin, C. L. & Lai, S. W. Nationwide case\u2013control study examining the association between tamoxifen use and Alzheimer\u2019s disease in aged women with breast cancer in Taiwan. Front. Pharmacol. 8, 612 (2017).","journal-title":"Front. Pharmacol."},{"key":"1244_CR229","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.1541","volume":"3","author":"GL Branigan","year":"2020","unstructured":"Branigan, G. L., Soto, M., Neumayer, L., Rodgers, K. & Brinton, R. D. Association between hormone-modulating breast cancer therapies and incidence of neurodegenerative outcomes for women with breast cancer. JAMA Netw. Open 3, e201541 (2020).","journal-title":"JAMA Netw. Open"},{"key":"1244_CR230","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.3390\/cancers14205132","volume":"14","author":"CJ Curtaz","year":"2022","unstructured":"Curtaz, C. J., Kiesel, L., Meybohm, P., W\u00f6ckel, A. & Burek, M. Anti-hormonal therapy in breast cancer and its effect on the blood\u2013brain barrier. Cancers 14, 5132 (2022).","journal-title":"Cancers"},{"key":"1244_CR231","doi-asserted-by":"publisher","unstructured":"Li, Y. et al. Cell-type-directed network-correcting combination therapy for Alzheimer\u2019s disease. Cell https:\/\/doi.org\/10.1016\/j.cell.2025.06.035 (2025).","DOI":"10.1016\/j.cell.2025.06.035"},{"key":"1244_CR232","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2021-003377","author":"IB Abdallah","year":"2022","unstructured":"Abdallah, I. B. et al. Cognitive complaints during breast cancer endocrine therapy: aromatase inhibitors versus tamoxifen. BMJ Support. Palliat. Care https:\/\/doi.org\/10.1136\/bmjspcare-2021-003377 (2022).","journal-title":"BMJ Support. Palliat. Care"},{"key":"1244_CR233","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1517\/14740338.2015.1014799","volume":"14","author":"AJ Ellis","year":"2015","unstructured":"Ellis, A. J., Hendrick, V. M., Williams, R. & Komm, B. S. Selective estrogen receptor modulators in clinical practice: a safety overview. Expert. Opin. Drug. Saf. 14, 921\u2013934 (2015).","journal-title":"Expert. Opin. Drug. Saf."},{"key":"1244_CR234","first-page":"1","volume":"4","author":"C Criscitiello","year":"2010","unstructured":"Criscitiello, C., Fumagalli, D., Saini, K. S. & Loi, S. Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection. Onco Targets Ther. 4, 1\u201311 (2010).","journal-title":"Onco Targets Ther."},{"key":"1244_CR235","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0140-6736(85)90966-3","volume":"1","author":"C Rose","year":"1985","unstructured":"Rose, C. et al. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet 1, 16\u201319 (1985).","journal-title":"Lancet"},{"key":"1244_CR236","doi-asserted-by":"publisher","first-page":"100869","DOI":"10.1016\/j.yfrne.2020.100869","volume":"59","author":"AM Novick","year":"2020","unstructured":"Novick, A. M., Scott, A. T., Neill Epperson, C. & Schneck, C. D. Neuropsychiatric effects of tamoxifen: challenges and opportunities. Front. Neuroendocrinol. 59, 100869 (2020).","journal-title":"Front. Neuroendocrinol."},{"key":"1244_CR237","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2826.2011.02156.x","volume":"24","author":"MA Arevalo","year":"2012","unstructured":"Arevalo, M. A., Diz-Chaves, Y., Santos-Galindo, M., Bellini, M. J. & Garcia-Segura, L. M. Selective oestrogen receptor modulators decrease the inflammatory response of glial cells. J. Neuroendocrinol. 24, 183\u2013190 (2012).","journal-title":"J. Neuroendocrinol."},{"key":"1244_CR238","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1523\/JNEUROSCI.1530-18.2019","volume":"39","author":"KA Rankin","year":"2019","unstructured":"Rankin, K. A. et al. Selective estrogen receptor modulators enhance CNS remyelination independent of estrogen receptors. J. Neurosci. 39, 2184\u20132194 (2019).","journal-title":"J. Neurosci."},{"key":"1244_CR239","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1021\/acs.jmedchem.5b01696","volume":"59","author":"Z Korade","year":"2016","unstructured":"Korade, Z. et al. The effect of small molecules on sterol homeostasis: measuring 7-dehydrocholesterol in Dhcr7-deficient Neuro2a cells and human fibroblasts. J. Med. Chem. 59, 1102\u20131115 (2016).","journal-title":"J. Med. Chem."},{"key":"1244_CR240","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1124\/mol.54.3.591","volume":"54","author":"FF Moebius","year":"1998","unstructured":"Moebius, F. F. et al. Pharmacological analysis of sterol \u03948\u2013\u03947 isomerase proteins with (3H)ifenprodil. Mol. Pharmacol. 54, 591\u2013598 (1998).","journal-title":"Mol. Pharmacol."},{"key":"1244_CR241","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1200\/JCO.1995.13.12.2900","volume":"13","author":"H Gylling","year":"1995","unstructured":"Gylling, H. et al. Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer. J. Clin. Oncol. 13, 2900\u20132905 (1995).","journal-title":"J. Clin. Oncol."},{"key":"1244_CR242","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41586-018-0360-3","volume":"560","author":"Z Hubler","year":"2018","unstructured":"Hubler, Z. et al. Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination. Nature 560, 372\u2013376 (2018).","journal-title":"Nature"},{"key":"1244_CR243","doi-asserted-by":"publisher","first-page":"4819","DOI":"10.1021\/acs.jmedchem.3c02396","volume":"67","author":"R Dorel","year":"2024","unstructured":"Dorel, R. et al. Discovery and optimization of selective brain-penetrant EBP inhibitors that enhance oligodendrocyte formation. J. Med. Chem. 67, 4819\u20134832 (2024).","journal-title":"J. Med. Chem."},{"key":"1244_CR244","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1200\/JCO.2012.43.0116","volume":"30","author":"TA Ahles","year":"2012","unstructured":"Ahles, T. A., Root, J. C. & Ryan, E. L. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J. Clin. Oncol. 30, 3675\u20133686 (2012).","journal-title":"J. Clin. Oncol."},{"key":"1244_CR245","doi-asserted-by":"publisher","first-page":"5899728","DOI":"10.1155\/2022\/5899728","volume":"2022","author":"AC Apple","year":"2022","unstructured":"Apple, A. C. et al. Longitudinal trajectories of memory performance in patients with early-stage breast cancer. J. Oncol. 2022, 5899728 (2022).","journal-title":"J. Oncol."},{"key":"1244_CR246","volume":"7","author":"YJ Kim","year":"2021","unstructured":"Kim, Y. J., Soto, M., Branigan, G. L., Rodgers, K. & Brinton, R. D. Association between menopausal hormone therapy and risk of neurodegenerative diseases: implications for precision hormone therapy. Alzheimers Dement. 7, e12174 (2021).","journal-title":"Alzheimers Dement."},{"key":"1244_CR247","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","volume":"374","author":"HN Hodis","year":"2016","unstructured":"Hodis, H. N. et al. Vascular effects of early versus late postmenopausal treatment with estradiol. N. Engl. J. Med. 374, 1221\u20131231 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1244_CR248","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1212\/WNL.0000000000002980","volume":"87","author":"VW Henderson","year":"2016","unstructured":"Henderson, V. W. et al. Cognitive effects of estradiol after menopause: a randomized trial of the timing hypothesis. Neurology 87, 699\u2013708 (2016).","journal-title":"Neurology"},{"key":"1244_CR249","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001833","volume":"12","author":"CE Gleason","year":"2015","unstructured":"Gleason, C. E. et al. Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-cognitive and affective study. PLoS Med. 12, e1001833 (2015).","journal-title":"PLoS Med."},{"key":"1244_CR250","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1212\/WNL.0000000000002970","volume":"87","author":"K Kantarci","year":"2016","unstructured":"Kantarci, K. et al. Effects of hormone therapy on brain structure: a randomized controlled trial. Neurology 87, 887\u2013896 (2016).","journal-title":"Neurology"},{"key":"1244_CR251","doi-asserted-by":"publisher","first-page":"e1404","DOI":"10.1212\/WNL.0000000000005325","volume":"90","author":"K Kantarci","year":"2018","unstructured":"Kantarci, K. et al. Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial. Neurology 90, e1404\u2013e1412 (2018).","journal-title":"Neurology"},{"key":"1244_CR252","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/GME.0000000000001326","volume":"26","author":"VM Miller","year":"2019","unstructured":"Miller, V. M. et al. The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned. Menopause 26, 1071\u20131084 (2019).","journal-title":"Menopause"},{"key":"1244_CR253","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/GME.0000000000001472","volume":"27","author":"SR El Khoudary","year":"2020","unstructured":"El Khoudary, S. R. et al. Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: the keeps trial. Menopause 27, 255\u2013262 (2020).","journal-title":"Menopause"},{"key":"1244_CR254","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/13697137.2020.1804545","volume":"24","author":"VM Miller","year":"2021","unstructured":"Miller, V. M. et al. Lessons from KEEPS: the Kronos early estrogen prevention study. Climacteric 24, 139\u2013145 (2021).","journal-title":"Climacteric"},{"key":"1244_CR255","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.yfrne.2018.07.001","volume":"50","author":"MK Houtchens","year":"2018","unstructured":"Houtchens, M. K. & Bove, R. A case for gender-based approach to multiple sclerosis therapeutics. Front. Neuroendocrinol. 50, 123\u2013134 (2018).","journal-title":"Front. Neuroendocrinol."},{"key":"1244_CR256","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","volume":"92","author":"MT Wallin","year":"2019","unstructured":"Wallin, M. T. et al. The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology 92, e1029\u2013e1040 (2019).","journal-title":"Neurology"},{"key":"1244_CR257","unstructured":"OCTOPUS: Optimal Clinical Trials Platform for Multiple Sclerosis. OCTOPUS https:\/\/ms-octopus.mrcctu.ucl.ac.uk (2026)."},{"key":"1244_CR258","unstructured":"ChariotMS \u2014 cladribine to halt deterioration in people with advanced multiple sclerosis. US National Library of Medicine https:\/\/clinicaltrials.gov\/study\/NCT04695080 (2025)."},{"key":"1244_CR259","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1101\/lm.034033.113","volume":"21","author":"AM Fortress","year":"2014","unstructured":"Fortress, A. M., Kim, J., Poole, R. L., Gould, T. J. & Frick, K. M. 17\u03b2-Estradiol regulates histone alterations associated with memory consolidation and increases Bdnf promoter acetylation in middle-aged female mice. Learn. Mem. 21, 457\u2013467 (2014).","journal-title":"Learn. Mem."},{"key":"1244_CR260","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1007\/s11357-024-01133-z","volume":"46","author":"R Cervera-Juanes","year":"2024","unstructured":"Cervera-Juanes, R. et al. Modulation of neural gene networks by estradiol in old rhesus macaque females. Geroscience 46, 5819\u20135841 (2024).","journal-title":"Geroscience"},{"key":"1244_CR261","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.3390\/ijms21093177","volume":"21","author":"T Kov\u00e1cs","year":"2020","unstructured":"Kov\u00e1cs, T., Szab\u00f3-Meleg, E. & \u00c1brah\u00e1m, I. M. Estradiol-Induced epigenetically mediated mechanisms and regulation of gene expression. Int. J. Mol. Sci. 21, 3177 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1244_CR262","doi-asserted-by":"publisher","first-page":"104642","DOI":"10.1016\/j.neuint.2019.104642","volume":"133","author":"MJ Bertogliat","year":"2020","unstructured":"Bertogliat, M. J., Morris-Blanco, K. C. & Vemuganti, R. Epigenetic mechanisms of neurodegenerative diseases and acute brain injury. Neurochem. Int. 133, 104642 (2020).","journal-title":"Neurochem. Int."},{"key":"1244_CR263","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12547","volume":"30","author":"D Adhya","year":"2018","unstructured":"Adhya, D. et al. Understanding the role of steroids in typical and atypical brain development: advantages of using a \u2018brain in a dish\u2019 approach. J. Neuroendocrinol. 30, e12547 (2018).","journal-title":"J. Neuroendocrinol."},{"key":"1244_CR264","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-021-04330-4","volume":"602","author":"I Kelava","year":"2022","unstructured":"Kelava, I., Chiaradia, I., Pellegrini, L., Kalinka, A. T. & Lancaster, M. A. Androgens increase excitatory neurogenic potential in human brain organoids. Nature 602, 112\u2013116 (2022).","journal-title":"Nature"},{"key":"1244_CR265","first-page":"3","volume":"118","author":"RB Lipton","year":"2005","unstructured":"Lipton, R. B. & Bigal, M. E. The epidemiology of migraine. Am. J. Med. Suppl. 118, 3\u201310 (2005).","journal-title":"Am. J. Med. Suppl."},{"key":"1244_CR266","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1007\/s00415-023-12047-9","volume":"271","author":"A Habbestad","year":"2024","unstructured":"Habbestad, A. et al. Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study. J. Neurol. 271, 1610\u20131617 (2024).","journal-title":"J. Neurol."},{"key":"1244_CR267","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1177\/13524585231197056","volume":"29","author":"D Morales-Rodriguez","year":"2023","unstructured":"Morales-Rodriguez, D. et al. Well-being at midlife: correlates of mental health in ambulatory menopausal women with multiple sclerosis. Mult. Scler. 29, 1493\u20131502 (2023).","journal-title":"Mult. Scler."},{"key":"1244_CR268","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1136\/jnnp-2019-320587","volume":"90","author":"D Baroncini","year":"2019","unstructured":"Baroncini, D. et al. Impact of natural menopause on multiple sclerosis: a multicentre study. J. Neurol. Neurosurg. Psychiatry 90, 1201\u20131206 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1244_CR269","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210228","volume":"104","author":"H Silverman","year":"2025","unstructured":"Silverman, H. et al. Association of menopause with functional outcomes and disease biomarkers in women with multiple sclerosis. Neurology 104, e210228 (2025).","journal-title":"Neurology"},{"key":"1244_CR270","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000496374","volume":"80","author":"F Ladeira","year":"2018","unstructured":"Ladeira, F. et al. The Influence of Menopause in Multiple Sclerosis Course: a longitudinal cohort study. Eur. Neurol. 80, 223\u2013227 (2018).","journal-title":"Eur. Neurol."},{"key":"1244_CR271","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/ene.14782","volume":"29","author":"S Otero-Romero","year":"2022","unstructured":"Otero-Romero, S. et al. Menopause does not modify disability trajectories in a longitudinal cohort of women with clinically isolated syndrome and multiple sclerosis followed from disease onset. Eur. J. Neurol. 29, 1075\u20131081 (2022).","journal-title":"Eur. J. Neurol."},{"key":"1244_CR272","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/1352458512451510","volume":"19","author":"M Tutuncu","year":"2013","unstructured":"Tutuncu, M. et al. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult. Scler. 19, 188\u2013198 (2013).","journal-title":"Mult. Scler."},{"key":"1244_CR273","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1007\/s00415-024-12452-8","volume":"271","author":"S Arnett","year":"2024","unstructured":"Arnett, S. et al. Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis. J. Neurol. 271, 4794\u20134812 (2024).","journal-title":"J. Neurol."},{"key":"1244_CR274","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000339","volume":"4","author":"R Bove","year":"2017","unstructured":"Bove, R. et al. Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study. Neurol. Neuroimmunol. Neuroinflamm. 4, e339 (2017).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1244_CR275","doi-asserted-by":"publisher","first-page":"e1171","DOI":"10.1212\/WNL.0000000000008903","volume":"94","author":"E Cort\u00e9s-Vicente","year":"2020","unstructured":"Cort\u00e9s-Vicente, E. et al. Clinical and therapeutic features of myasthenia gravis in adults based on age at onset. Neurology 94, e1171\u2013e1180 (2020).","journal-title":"Neurology"},{"key":"1244_CR276","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0002-9378(16)32829-0","volume":"137","author":"HO Williamson","year":"1980","unstructured":"Williamson, H. O. et al. Myasthenia gravis, premature menopause, and thyroid autoimmunity. Am. J. Obstet. Gynecol. 137, 893\u2013901 (1980).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1244_CR277","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/mus.20067","volume":"30","author":"MM Ryan","year":"2004","unstructured":"Ryan, M. M. & Jones, H. R. Jr. Myasthenia gravis and premature ovarian failure. Muscle Nerve 30, 231\u2013233 (2004).","journal-title":"Muscle Nerve"},{"key":"1244_CR278","first-page":"107","volume":"18","author":"A Hoek","year":"1997","unstructured":"Hoek, A., Schoemaker, J. & Drexhage, H. A. Premature ovarian failure and ovarian autoimmunity. Endocr. Rev. 18, 107\u2013134 (1997).","journal-title":"Endocr. Rev."},{"key":"1244_CR279","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1177\/0300060519863525","volume":"47","author":"L Cao","year":"2019","unstructured":"Cao, L., Liu, W. & Zhu, Z. Clinical characteristics and relationship between myasthenia gravis and premature ovarian failure: report of two cases. J. Int. Med. Res. 47, 3992\u20133997 (2019).","journal-title":"J. Int. Med. Res."},{"key":"1244_CR280","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/0002-9378(79)90869-X","volume":"134","author":"JA Board","year":"1979","unstructured":"Board, J. A., Redwine, F. O., Moncure, C. W., Frable, W. J. & Taylor, J. R. Identification of differing etiologies of clinically diagnosed premature menopause. Am. J. Obstet. Gynecol. 134, 936\u2013944 (1979).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1244_CR281","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1212\/WNL.63.10_suppl_4.S40","volume":"63","author":"GK Bergey","year":"2004","unstructured":"Bergey, G. K. Initial treatment of epilepsy: special issues in treating the elderly. Neurology 63, S40\u2013S48 (2004).","journal-title":"Neurology"},{"key":"1244_CR282","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.maturitas.2010.03.026","volume":"66","author":"CT Erel","year":"2010","unstructured":"Erel, C. T. et al. EMAS position statement: managing the menopause in women with epilepsy. Maturitas 66, 327\u2013328 (2010).","journal-title":"Maturitas"},{"key":"1244_CR283","doi-asserted-by":"publisher","first-page":"497","DOI":"10.4065\/78.4.497","volume":"78","author":"J Liporace","year":"2003","unstructured":"Liporace, J. & D\u2019Abreu, A. Epilepsy and women\u2019s health: family planning, bone health, menopause, and menstrual-related seizures. Mayo Clin. Proc. 78, 497\u2013506 (2003).","journal-title":"Mayo Clin. Proc."},{"key":"1244_CR284","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2147\/NSS.S101186","volume":"8","author":"A Cairns","year":"2016","unstructured":"Cairns, A., Poulos, G. & Bogan, R. Sex differences in sleep apnea predictors and outcomes from home sleep apnea testing. Nat. Sci. Sleep 8, 197\u2013205 (2016).","journal-title":"Nat. Sci. Sleep"},{"key":"1244_CR285","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/j.1365-2362.2003.01278.x","volume":"33","author":"O Resta","year":"2003","unstructured":"Resta, O. et al. Gender, age and menopause effects on the prevalence and the characteristics of obstructive sleep apnea in obesity. Eur. J. Clin. Invest. 33, 1084\u20131089 (2003).","journal-title":"Eur. J. Clin. Invest."},{"key":"1244_CR286","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/aje\/kwy011","volume":"187","author":"T Huang","year":"2018","unstructured":"Huang, T. et al. Type of menopause, age at menopause, and risk of developing obstructive sleep apnea in postmenopausal women. Am. J. Epidemiol. 187, 1370\u20131379 (2018).","journal-title":"Am. J. Epidemiol."},{"key":"1244_CR287","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","volume":"32","author":"E Longinetti","year":"2019","unstructured":"Longinetti, E. & Fang, F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr. Opin. Neurol. 32, 771\u2013776 (2019).","journal-title":"Curr. Opin. Neurol."},{"key":"1244_CR288","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/brain\/awac470","volume":"146","author":"L Chapman","year":"2023","unstructured":"Chapman, L., Cooper-Knock, J. & Shaw, P. J. Physical activity as an exogenous risk factor for amyotrophic lateral sclerosis: a review of the evidence. Brain 146, 1745\u20131757 (2023).","journal-title":"Brain"},{"key":"1244_CR289","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1001\/jamaneurol.2015.4487","volume":"73","author":"YL Eaglehouse","year":"2016","unstructured":"Eaglehouse, Y. L., Talbott, E. O., Chang, Y. & Kuller, L. H. Participation in physical activity and risk for amyotrophic lateral sclerosis mortality among postmenopausal women. JAMA Neurol. 73, 329\u2013336 (2016).","journal-title":"JAMA Neurol."},{"key":"1244_CR290","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00415-012-6665-5","volume":"260","author":"S de Jong","year":"2013","unstructured":"de Jong, S. et al. Endogenous female reproductive hormones and the risk of amyotrophic lateral sclerosis. J. Neurol. 260, 507\u2013512 (2013).","journal-title":"J. Neurol."},{"key":"1244_CR291","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/mus.27942","volume":"68","author":"MC Gonzalez Deniselle","year":"2023","unstructured":"Gonzalez Deniselle, M. C. et al. Exposure to endogenous and exogenous sex hormones and reproductive history influence prognosis in women with ALS. Muscle Nerve 68, 414\u2013421 (2023).","journal-title":"Muscle Nerve"},{"key":"1244_CR292","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1159\/000516344","volume":"55","author":"J Raymond","year":"2021","unstructured":"Raymond, J., Mehta, P., Larson, T., Pioro, E. P. & Horton, D. K. Reproductive history and age of onset for women diagnosed with amyotrophic lateral sclerosis: data from the National ALS Registry: 2010-2018. Neuroepidemiology 55, 416\u2013424 (2021).","journal-title":"Neuroepidemiology"},{"key":"1244_CR293","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000095550","volume":"27","author":"RA Popat","year":"2006","unstructured":"Popat, R. A. et al. Effect of reproductive factors and postmenopausal hormone use on the risk of amyotrophic lateral sclerosis. Neuroepidemiology 27, 117\u2013121 (2006).","journal-title":"Neuroepidemiology"},{"key":"1244_CR294","first-page":"248","volume":"11","author":"C Gillis","year":"2019","unstructured":"Gillis, C., Mirzaei, F., Potashman, M., Ikram, M. A. & Maserejian, N. The incidence of mild cognitive impairment: a systematic review and data synthesis. Alzheimers Dement. 11, 248\u2013256 (2019).","journal-title":"Alzheimers Dement."},{"key":"1244_CR295","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1212\/CON.0000000000000687","volume":"25","author":"MF Mendez","year":"2019","unstructured":"Mendez, M. F. Early-onset Alzheimer disease and its variants. Continuum 25, 34\u201351 (2019).","journal-title":"Continuum"},{"key":"1244_CR296","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.parkreldis.2019.06.001","volume":"65","author":"R Mehanna","year":"2019","unstructured":"Mehanna, R. & Jankovic, J. Young-onset Parkinson\u2019s disease: its unique features and their impact on quality of life. Parkinsonism Relat. Disord. 65, 39\u201348 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1244_CR297","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-025-01470-2","volume":"26","author":"J Hickman","year":"2025","unstructured":"Hickman, J. et al. Early-onset Parkinson\u2019s disease: unique features and management approaches. Curr. Neurol. Neurosci. Rep. 26, 3 (2025).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"1244_CR298","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1007\/s00415-024-12258-8","volume":"271","author":"R Bovenzi","year":"2024","unstructured":"Bovenzi, R. et al. A biological characterization of patients with postmenopausal Parkinson\u2019s disease. J. Neurol. 271, 3610\u20133615 (2024).","journal-title":"J. Neurol."},{"key":"1244_CR299","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3109\/09540261.2013.776523","volume":"25","author":"CU Onyike","year":"2013","unstructured":"Onyike, C. U. & Diehl-Schmid, J. The epidemiology of frontotemporal dementia. Int. Rev. Psychiatry 25, 130\u2013137 (2013).","journal-title":"Int. Rev. Psychiatry"},{"key":"1244_CR300","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.3390\/jcm12154999","volume":"12","author":"S Bukhari","year":"2023","unstructured":"Bukhari, S., Yaghi, S. & Bashir, Z. Stroke in young adults. J. Clin. Med. 12, 4999 (2023).","journal-title":"J. Clin. Med."},{"key":"1244_CR301","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0140-6736(23)00085-5","volume":"401","author":"S Lederman","year":"2023","unstructured":"Lederman, S. et al. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet 401, 1091\u20131102 (2023).","journal-title":"Lancet"},{"key":"1244_CR302","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/GME.0000000000002340","volume":"31","author":"N Santoro","year":"2024","unstructured":"Santoro, N. et al. Fezolinetant treatment of moderate-to-severe vasomotor symptoms due to menopause: effect of intrinsic and extrinsic factors in two phase 3 studies (SKYLIGHT 1 and 2. Menopause 31, 247\u2013257 (2024).","journal-title":"Menopause"},{"key":"1244_CR303","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3389\/fphar.2018.01452","volume":"9","author":"DB Wilhelms","year":"2018","unstructured":"Wilhelms, D. B. et al. CGRP is critical for hot flushes in ovariectomized mice. Front. Pharmacol. 9, 1452 (2018).","journal-title":"Front. Pharmacol."},{"key":"1244_CR304","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00042192-200007010-00005","volume":"7","author":"YA Wyon","year":"2000","unstructured":"Wyon, Y. A., Spetz, A. C., Theodorsson, G. E. & Hammar, M. L. Concentrations of calcitonin gene-related peptide and neuropeptide Y in plasma increase during flushes in postmenopausal women. Menopause 7, 25\u201330 (2000).","journal-title":"Menopause"},{"key":"1244_CR305","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/GME.0000000000002200","volume":"30","author":"No author group","year":"2023","unstructured":"No author group The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause 30, 573\u2013590 (2023).","journal-title":"Menopause"},{"key":"1244_CR306","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70119","volume":"32","author":"JN Panicker","year":"2025","unstructured":"Panicker, J. N. et al. European Academy of Neurology (EAN)\/European Federation of Autonomic Societies (EFAS)\/International Neuro-Urology Society (INUS) Guidelines for Practising Neurologists on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms (NEUROGED Guidelines). Eur. J. Neurol. 32, e70119 (2025).","journal-title":"Eur. J. Neurol."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01244-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01244-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:03:18Z","timestamp":1787832198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01244-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":306,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1244"],"URL":"https:\/\/doi.org\/10.1038\/s41582-026-01244-5","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"3 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.B. has received research funding from the National Institutes of Health, National Multiple Sclerosis Society and Department of Defense and from Biogen, Eli Lilly, F Hoffman Laroche and Novartis. R.B. has also received personal fees for consulting or advisory board services from Alexion, Amgen, EMD Serono, Sanofi Genzyme and TG Therapeutics. R.D. has received grants from Biogen, Celgene (now Bristol Myers Squibb) and Merck. R.D. has received personal fees from Biogen, Esai, Janssen, Merck, Novartis, Roche, Sandoz, Sanofi and Teva.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}